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ABSTRACT
The halo-v iny lic  acids c is -  and trans-3-brom oacrylic acid  and 
dibrom om aleic acid  w ere te s ted  as inhibitors o f  D -am ino acid  oxidase 
(DAAO) with D -phenylglycine as substrate a t pH 8.3. K[ values for c is -  
and t r a n s-3 -br om oacr y lic  acids as com p etitive  inhibitors o f  DAAO w ere 
4.5 x 10-3 ^  ancj 8.2 x 10“5 M, resp ective ly . A procedure involving the  
in jection  o f inhibitors into a reaction  c e ll  contain ing enzym e and 
substrate showed tim e-dependent loss o f a c tiv ity  in a ll cases, suggesting  
irreversib le inactivation  o f  the enzym e. Injections o f benzoic acid, a 
known reversib le, com p etitive  inhibitor o f  DAAO showed no tim e  
dependence in in activation  o f  the enzym e. Comparisons o f relative  
strengths o f inhibition am ong these compounds and with c is -  and trans-3 -  
ch loroacrylic acids showed trans stronger than c is , brom o- stronger than 
ch loro-substitu ted  compounds, and dibrom om aleic acid  stronger than 
m ono-substituted c is  compounds. A ll five com pounds w ere a ctiv e  s ite  
directed  inhibitors based on loss o f inactivation  in the presence of 
benzoate. DAAO in activa ted  by trans-3 -brom oacr y lic  acid  was dialyzed  
for 96 hours against 0.5 M K 3r/0.05 M sodium pyrophosphate at pH 8.3, 
0°C ; a fter  this tim e, nearly a ll a c tiv ity  o f the enzym e was regained. 
A fter a 24 hour d ialysis, only 13% o f the original enzym e a c tiv ity  
returned. The possib ility  o f reduced FAD co fa cto r  actin g  as a nucleophile  
in the presence o f substrate to  in teract with trans-3-brom oacrylic acid  
was te s ted  under a n itrogen atm osphere to  prevent reoxidation  o f  FAD, 
but no in teraction  was observed. N ucleophilic substitution  by A ddition- 
Elim ination a t severa l am ino acid  residues was exam ined as a possible  
m echanism  for the inhibition.
v i i i
THE IRREVERSIBLE INHIBITION OF D-AMINO ACID OXID ASE WITH 
TRANS -3-BROMO ACRYLIC ACID AND FOUR OTHER HALO-VINYLIC ACIDS
CHAPTER 1 
INTRODUCTION
A. The C hem istry o f D-Am ino Acid Oxidase
1. H istorical and P hysiological Background
The ex ten sive  research  on the m echanism  and function  o f  D-am ino  
acid  oxidase (D -am ino acid: oxygen oxidoreductase (deam inating), E.C.
1 .4 .3 .3) began in 1935 when Hans Krebs observed the oxidation o f both the  
L- and D -isom ers o f  am ino acids by mammalian liver and kidney 
hom ogenates (1). Since then, much has been revealed  about this m odel 
flavoprotein  oxidase, y e t much rem ains unknown. As a flavoprotein  
oxidase, D -am ino acid  oxidase (DAAO) is c la ss ified  w ith other flavin  
dependent oxidases like monoam ine oxidase, L-amino acid  oxidase, g lucose  
oxidase, and others a ll contain ing flavin  adenine d inucleotide (FAD) as a 
co fa cto r  (2). A erobically , the c a ta ly tic  reaction  o f DAAO with D -am ino  
acids involves the oxidation o f the am ino acid  to hydrogen peroxide and the  
corresponding im ino acid , which is then hydrolyzed non-enzym atica lly  to  
yield  the a -k e to  acid  and am m onia (Fig. 1). For long reaction  tim es, the  
hydrogen peroxide form ed w ill reac t n on-enzym atica lly  with the a -k e to  
acid  as shown in Fig. 2, but the presence o f  the enzym e ca ta la se  in the  
reaction  m ixture prevents this by breaking down the peroxide. In addition  
to the oxidation o f  D-am ino acids, DAAO also ca ta ly zes  their form ation.
Among the am ino acids, DAAO exh ib its an alm ost absolute  
sp e c if ic ity  for the D -isom ers, ex cep t for a sm all amount o f  a c tiv ity  with 
L-proline and L-3, 4-dehydroproline and a lso  with g lycin e, which is neither
2
3nh2
R— CH—-COOH
FIGURE 1.
The ca ta ly tic  reaction  o f  DAAO.
DAAO
FAD
R— C— COOH
dri f t s  
out of  
act.  s i t e
h2o
0
FADH2/DAA0 
(reduced enzyme)
FAD/DAAO 
+
R— C— COOH + NH.
H2 O2
FIGURE 2.
N on-enzym atic  reaction  o f H2 O2 and k eto  acid.
5D nor L (3). This marked sp e c if ic ity  for D-am ino acids is the basis for 
much o f  the curiosity  surrounding the en zym e. DAAO ex ists  in nearly a ll 
m am m alian kidney, liver and brain sy stem s as w ell as in other vertebrates, 
such as birds, rep tiles , am phibians, and fish , and in invertebrates like 
b acteria  (4). H ow ever, the re la tive  absence o f  D -am ino acids in the 
m am m alian m etabolism  m akes the en zy m e’s presence som ew hat puzzling. 
Although the primary s ite  o f am ino acids in humans is in protein, only L- 
am ino acids make up this structure. Y et Holme and Goldberg (5) have 
shown that DAAO a c tiv ity  in human liver and kidney is approxim ately ten  
tim es that o f L-am ino acid  oxidase (LAAO) in the sam e organs, and while  
they d e tec ted  a trace amount o f  DAAO a ctiv ity  in the brain, they found no 
LAAO a ctiv ity  there. Therein lie s  the goal o f much o f  the current 
research  on DAAO, nam ely, to  determ ine the true physiological function o f  
the enzym e.
R ecen t literatu re has produced sev era l m ethods by which the  
function  o f  DAAO in the m am m alian m etabolism  could possibly be 
deduced. The m ost im portant o f  th ese  u tilizes  inform ation about the  
en zym e’s a c tiv e  s ite  in the syn thesis o f a very sp ec ific , irreversible  
inhibitor o f the enzym e, ca lled  a su icide inhibitor or su icide substrate. If 
te sted  in v ivo , any consequences o f the inhibitor’s presence could provide  
valuable inform ation about the en zym e’s function. This m ethod, o f course, 
p laces som e rather s tr ic t  restr iction s on the inhibitor to be used (6 ). The 
inhibitor cannot be a very rea c tiv e  compound because it could reac t with  
en zym es other than the target enzym e or a t a position  other than the 
en zym e’s a c tiv e  s ite . In order to  insure reaction  a t the a c tiv e  s ite , the  
inhibitor would resem bles the en zym e’s norm al substrate. In addition, a 
good su icide inhibitor, upon in teraction  with the a c tiv e  s ite , would be
6converted  to a reac tive  form by the c a ta ly tic  process o f  the enzym e. A ll 
o f these conditions com bine to  y ield  a cova len tly  a ltered  enzym e m olecule  
that has com m itted  "suicide” on this pseudo-substrate.
As y e t, no p oten tia l su icide inhibitors o f DAAO have been tested  in 
vivo . H ow ever, Konno and Yasumura (7) applied the basic prem ise o f  this 
technique to  another with som e su ccess. They found a m utant for the 
mouse DAAO gen e and were thus able to produce a strain  o f m ice w ith no 
kidney DAAO a c tiv ity . T heoretica lly , i f  DAAO is im portant in the  
m etabolism , som e d ifferen ces  b etw een  the norm al and mutant strains of 
m ice should have been seen , but no d ifferen ces  w ere observed.
These resu lts are questionable, how ever, given  the amount o f  
evidence that has surfaced  recen tly  to support the im portance o f  DAAO in 
the m am m alian m etabolism . H am ilton and Buckthal (8 ) have researched  
the enzym e ex ten siv e ly  and have shown that severa l am ines, esp ecia lly  
cysteam in e, when reacted  w ith g lyoxy la te  provide good substrates for 
DAAO. This fa c t  is ev ident from their low  Km values, since the low er the 
Km, the b e tter  the substrate for that en zym e. F itzpatrick  and M assey (9) 
fo llow ed  up th is research by showing that th iazo lid in e-2 -carboxylic acid  is 
the resu ltant substrate for DAAO when cysteam in e rea c ts  w ith g lyoxy la te . 
The high le v e ls  o f  cysteam in e and g lyoxy la te  in rat liver and kidney support 
the hypothesis that th iazo lid in e-2-carb oxylic  acid  could a c t as a 
physio logical substrate for DAAO. Ham ilton and Buckthal (10) have  
perform ed numerous inhibition studies on DAAO using severa l ca tegor ies  o f  
human m etab o lites, one o f  the m ost im portant o f  which was the d iuretics, 
including m ersalyl, furosem ide, and ethacryn ic acid, which a ll inhibited  
DAAO a ctiv ity . From this inform ation, DAAO is believed  to be involved in 
w ater and sodium resorption in the kidney as w ell as in the m aintenance o f
7normal blood pressure.
Another im portant study, perform ed by Just, e t  al. (11), im plicates  
DAAO in liver peroxisom e m etabolism . 3 y  inducing a hyperthyroid s ta te  in 
rats with the drug thyroxine, they observed a 61% increase in peroxisom al 
DAAO a c tiv ity  and a 32% increase in ca ta la se  a c tiv ity . Apparently DAAO 
is involved in the peroxisom al m etabolism  which may play a part in the 
oxidation o f long chain fa tty  acids. This oxidation is believed  to be 
im portant e ith er  in higher en ergetic  demands or possibly for the 
elim ination  o f ex ce ss  lipids and therm ogenesis. This la tter  assum ption has 
som e support in the work o f Locci-Cubeddu, e t  al. (12), who found that 
peroxisom al DAAO and ca ta la se  a c t iv it ie s  in rat brown adipose tissue  
underwent an incredibly large increase during the anim al’s adaptation to  
cold.
DAAO also appears to  have possible physio logica l functions in the  
brain, as the work o f Weimar and N eim s (13) has linked DAAO activ ity  
there to  certa in  sp ec if ic  ce lls  in the cerebellum  and brain stem . An 
induced hypothyroid s ta te  in newborn rats using propylthiouracil caused a 
67% d e fic it  in DAAO a c tiv ity  in those areas o f the brain. This condition  
could be reversed  by trea tm en t with thyroxine, a hyperthyroid inducer in 
norm al rats. This link b etw een  DAAO and thyroid m etabolism  was also  
evident in the lo ca liza tio n  o f  DAAO in tw o sp ec ific  types o f brain ce lls  
known to  be particularly sen sitive  to  thyroid horm one.
2. The Structure o f  DAAO
DAAO, like many other enzym es, contains a co fa c to r , flavin adenine 
dinucleotide (FAD), w ithout which it is ca ta ly tica lly  in active . Until 
recen tly , the primary structure o f  the apoenzym e and even  its  m olecular 
w eight had eluded researchers. The best e stim a tes  had been in the range
of 38,000-40 ,000  g /m ol. In 1982, how ever, Swenson and Ronchi, e t  al. (14), 
deduced the en tire primary stru ctu re o f DAAO, finding it to  contain 347 
am ino acid residues with a m olecular w eight o f 39,336 for the apoenzym e. 
The primary structure and summary o f am ino acid  con ten t appear as Fig. 3 
and Table 1. An in teresting  feature o f  the primary structure is the  
apparent order in the distribution o f  charged am ino acid  residues. The 
enzym e contains three internal regions, residues 39-98, 177-198, and 222-  
248, as w ell as the N -term inal end, which contain a lm ost no charged  
residues and, thus, are a lm ost com p lete ly  nonpolar and could be exp ected  
to  lie  internally in the tertiary  structure.
The elucidation  o f  the primary structure o f DAAO allow s for a b etter  
picture o f  its  a c tiv e  s ite . Previously, researchers had id en tified  severa l 
a ctiv e  s ite  am ino acid  residues through ch em ica l m odification , and now  
th ese  residues have been loca ted  in the primary structure. Table 2 lists  the 
ex a c t locations o f th ese  residues and the agen ts used to  id en tify  them . 
Nishino, e t  al. (15), have shown that 5 -d im eth ylam inoap th alen e-l-su lfon yl 
(or dansyl) chloride com p lete ly  in activa tes DAAO at an a c tiv e  s ite  
histid ine residue. Swenson, e t  al. (14) reproduced th is work to  show that 
the residue m odified is h istid ine 217. The presence o f  benzoic acid , a 
c la ss ica l com p etitive  inhibitor o f DAAO, p rotects  substantia lly  against 
inactivation  (15), providing evidence for m odification  at the a c tiv e  s ite  
because dansyl chloride must com pete with benzoate for the a c tiv e  s ite  of 
the DAAO m olecule.
Another a c tiv e  s ite  d irected  inactivator o f  DAAO, N -ch loro-D -  
leucin e, described by Ronchi, e t  al. (16), a ttack s a sp ec ific  tyrosine residue 
now known to  be tyrosine 224 (14). Again, benzoate reduces the amount o f  
inactivation , although only by 64% (16). A sim ilar situation  occurs with the
9FIGURE 3.
The primary structure o f  DAAO (14).
M e t - A r g - V a l - V a l - V a l - I I e - G l y - A l a - G l y - V a l - I l e - G l y - L e u - S e r - T h r -  15 
A T a - L e u - C y s - I l e - H i s - G l u - A r g - T y r - H i s - S e r - V a l - L e u - G l n - P r o - L e u -  30 
A s p - V a l - L y s - V a l - T y r - A l a - A s p - A r g - P h e - T h r - P r o - P h e - T h r - T h r - T h r -  45 
A s p - V a l - A l a - A l a - G l y - L e u - T r p - G l n - P r o - T y r - T h r - S e r - G l u - P r o - 5 e r -  60 
A s n - P r o - G l n - G l u - A l a - A s n - T r p - A s n - G l n - G l n - T h r - P h e - A s n - T y r - L e u -  75 
L e u - S e r - H i  s - 1 1e - G l y - S e r - P r o - A s n - A l a - A l a - A s n - M e t - G l v - L e u - T h r -  90 
P r o - V a 1- S e r - G 1y - T y r - A s n - L e u - P h e - A r g - G l u - A l a - V a l - P r o - A s p - P r o - 105 
T y r - T r p - L y s - A s p - M e t - V a l - L e u - G l y - P h e - A r g - L y s - L e u - T h r - P r o - A r g - 120 
G1 u - L e u - A s p - M e t - P h e - P r o - A s p - T y r - A r g - T y r - G l y - T r p - P h e - A s n - T h r - 1 35 
S e r - L e u - l i e - L e u - G l u - G l y - A r g - L y s - T y r - L e u - G l n - T r p - L e u - T h r - G l  u-1 50 
A r a - L e u - T h r - G l u - A r g - G l y - V a l - L y s - P h e - P h e - L e u - A r q - L y s - V a l - G 1 u - 1 65 
S e r - P h e - G l u - G l u - V a l - A l a - A r g - G l y - G l y - A l a - A s p - V a l - I l e - I l e - A s n - 1 8 0  
C y s - T h r - G l y - V a l - T r p - A l a - G l y - V a l - L e u - G l n - P r o - A s p - P r o - L e u - L e u - 195 
G1 n - P r o - G l y - A r g - G l y - G l  n - H e - H e - L y s - V a l  - A s p - A l a - P r o - T r p - L e u - 2 10 
L y s - A s n - P h e - H  e - I l e - T h r - H i s - A s p - L e u - G l u - A r g - G l y - I l e - T y r - A s n - 2 2 5  
S e r - P r o - T y r - I I e - I 1e - P r o - G l y - L e u - G l n - A l a - V a l - T h r - L e u - G l y - G l y - 2 4 0  
T h r - P h e - G l n - V a l - G l y - A s n - T  r p - A s n - G l u - I l e - A s n - A s n - I I e - G l n - A s p - 255 
Hi s - A s ~ - T h r - 1 1e - T r p - G l u - G l y - C y s - C y s - A r g - L e u - G l u - P r o - T h r - L e u - 2 7 0  
Lys - A s p - A1a - L y s - I I e - V a l - G l y - G l u - T y r - T h r - G l y - P h e - A r g - P r o - V a l  -285  
A r g - P r o - G l n - V a l - A r g - L e u - G l u - A r g - G l u - G l n - L e u - A r g - P h e - G l y - S e r - 3 0 0  
S e r - A s n - T h r - G l u - V a l - I I  e -Hi  s - A s n - T y r - G l y - H i  s - G l y - G l y - T y r - G l y - 315 
L e u - T h r - I l e - H i  s - T r p - G l y - C y s - A l a - L e u - G l u - V a l  -A 1 a - L y s - L e u - P h e - 3 3 C  
G l y - L y s - V a l - L e u - G l u - G l u - A r g - A s n - L e u - L e u - T h r - M e t - P r o - P r o - S e r - 3 4 5  
Hi s -L e u
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TABLE 1.
The am ino acid  con ten t o f DAAO (14).
A l a n i ne 17
A r g i n i n e 21
Aspa ra g i  ne 19
A s p a r t i c  Acid 13
C y s t e i n e 5
Glu tamic  Acid 22
Glu tamine 14
Glyci  ne 32
H i s t i d i  ne 9
I s o l e u c i n e 20
Leuc ine  36
Ly s i ne  12
Met h i on i ne  5
P h e n y l a l a n i n e  15
P r o l i n e  22
S e r i n e  13
T hr eo n i ne  22
Tryp tophan  10
T y r o s i n e  14
V a l i n e  26
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reagent fluorodinitrobenzene (FDNB) (15), which com p lete ly  in activa tes  
DAAO as the enzym e takes up tw o dinitrophenyl groups. Nishino, e t  a l., 
showed that this takes p lace at predom inantly tyrosine residues and that 
the presence o f b en zoate  reduces the am ount o f in activation  by allow ing  
the incorporation o f only one dinitrophenyl group. Swenson, e t al. (14), 
have shown tyrosine 55 to be the m odified residue in the absence o f  
benzoate and that considerable m odification  o f  lysine 204 also occurs.
A fourth m odifier o f  DAAO, reported by M arcotte and Walsh (17), is 
D -propargylglycine, which a c ts  as a su icide inhibitor o f  DAAO by 
cova len tly  a lkylating the protein , and thus, partially  inactivating  it. 
M arcotte and Walsh found that the enzym e, although not fu lly  in activated , 
b ecom es converted  into a c a ta ly tic  sp ec ies  with d ifferen t properties from  
those o f  the native enzym e. This cova len t m odification  occurs at h istidine  
307 and tyrosine 228 (14). B ecause the m odified enzym e reta ins a certain  
residual a c tiv ity  and cannot be further in activated , it  is unlikely that the  
m odification  takes p lace  a t the a c tiv e  s ite , rather, the a c tiv e  s ite  could  
undergo a structural change upon m odification  indicating that these  
residues are near that region.
Finally, tw o more inhibitors o f DAAO worth m entioning are 
cyclohexaned ione and butanedione (18,15). Both o f  th ese  inhibitors are 
b elieved  to  m odify a c tiv e  s ite  arginine residues, and the inhibition by 
cyclohexaned ione can be reduced substantially  by the presence o f 
b en zoate, indicating reaction  at the a c tiv e  s ite  o f DAAO. However, in 
n either case  has the m odified arginine residue been p recise ly  positioned in 
the prim ary structure.
Upon exam ination, one can see  that severa l o f the residues believed  
to  lie  a t the a c tiv e  s ite  o f DAAO, lysine 204, h istidine 217, tyrosine 224,
12
TABLE 2.
L ocation o f ch em ica lly  m odified amino acid  residues.
Enzyme Amino
I n a c t i -  P r o t e c t i o n  Acid Sequence  R e f e r -
Reagent________  v a t i o n  by Benzoa te  Modi f i ed  P o s i t i o n  ence
Dansyl  c h l o r i d e Complete P a r t i a l His 217 15
N - C h l o r o - D - l e u c i n e P a r t i a l P a r t i  al Tyr 224 16
F I u r o d i  ni t r o b e n z e n e Complete P a r t i a l Tyr 55 15
Lys 204
D - P r o p a r g y l g l y c i  ne P a r t i  al Not done His 307 17
Tyr 228
Cy c l ohexaned i  one Complete P a r t i a l Arg - 18
B u t a ne d i o n e Complete Net  done Arg - 15
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and tyrosine 228, are quite e lo se  togeth er in the prim ary structure. In 
addition, h istidine 307 lies  in the second half o f the structure with these  
four residues. The other FDNB m odified residue, tyrosine 55, lie s  in the  
region near the N -term inus o f the enzym e, which has been found to  be 
hom ologous to  im portant binding regions o f  tw o other flavoproteins, p -  
hydroxybenzoatehydroxylase and g lu tath ione reductase. Although tw o of 
the four am ino acid  residues that are b elieved  to  lie  at the a c tiv e  s ite  are 
also  within one o f  the three major nonpolar regions (residues 222-248) and, 
therefore, may e x is t  internally  in the protein , ev idence su ggests that 
residues 204-228 play a major role in the ca ta ly tic  reaction  o f the enzym e  
(14).
In addition to identifying severa l possible a c tiv a te  s ite  am ino acid  
residues, Swenson and Ronchi, e t  a l., perform ed ca lcu lation s based on the 
m ethod o f  Chou and Fasman (19) to  pred ict the secondary structure o f  
DAAO. These resu lts are shown as Fig. 4. The predicted  p ercentages o f  
the tw o major secondary structures in protein , the a -h e lix  and the 3 -  
p leated  sh eet, are 2396 and 30%, resp ective ly . The predictions a lso  suggest  
that the enzym e contains 16 3 -strands averaging 6.4 residues each; 10 a -  
h elices  averaging 7.9 residues; and 16 3 -turns, which aid in the  
construction  o f the tertiary  structure. As for supersecondary e lem en ts, 
DAAO appears to  contain only four 8 a 3  segm ents but no 3 a 3 a 3  unit, 
known as a Rossm an fold . Secondary e lem en ts  referred  to  as 3 -m eanders, 
which are 3 3 3  units, seem  to  occur at le a st  tw ice  in the structure. Lastly, 
su lfur-arom atic in teractions, which occur betw een  arom atic am ino acid  
residues and sulfur atom s to  help s ta b iliz e  the tertiary  structure o f the 
enzym e, take p lace approxim ately 14 tim es (14).
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FIGURE 4.
Diagram o f the pred icted  secondary structure o f DAAO. R esidues are 
represented  in h e lica l ( y ) ,  3 -sh e e t (V), 3 -turn ( Q ,  and random co il $»-•). 
The bold line represents the region hom ologous to g lutath ione reductase  
and p-hydroxybenzoate hydroxylase. The circled  one le tte r  codes  
in d icate the ch em ica lly  m odified amino acid  residues (14).
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3. Flavin Adenine D inucleotide, the C oenzym e o f  DAAO
Flavin adenine d inucleotide (FAD), the structure o f  which appears as 
Fig. 5, co n sists  o f a cen tra l structure referred  to  as the isoa lloxazine ring 
system  and a group ca lled  adenosyldiphosphoribityl a ttach ed  to  the N-10  
position  o f  the ring system . The nam e o f  this la tter  group refers to  the  
nitrogenous base adenine, the sugar D -ribose, and the tw o phosphates that 
com prise the group. The isoa lloxazin e ring serves as a donor and accep tor  
o f tw o hydrogen atom s which a tta ch  to  the N -l and N-5 positions o f  the  
ring system  by breaking the double bonds at those atom s. In the DAAO  
ca ta ly zed  reaction , the FAD co factor  plays a part in the rem oval o f H2 
from the D -am ino acid  to  produce the imino acid  (oxidation) and the  
addition o f  tw o hydrogen atom s to  O2 to  yield  H2 O2 (reduction).
Okuda, e t  a l. (20), have shown that the binding o f  FAD to  the  
apoenzym e is not very tigh t, with the co factor  bound to  the apoenzym e  
prim arily through hydrogen bonds at the N(3)H, 0(12), and 0(14) positions  
o f the isoalloxazine ring. In fa c t , exchange o f FAD m olecules in solution  
occurs quite readily . When equim olar am ounts o f DAAO holoenzym e and 
carbon-14-labelled  FAD w ere placed  in a solution at pH 8.3 and 25°C , only
0.8 m inutes were required for h a lf o f  the FAD to  be exchanged. The 
inclusion o f the co m p etitive  inhibitor b enzoic acid  in this m ixture produces 
in teresting  deviations, how ever. T h e . presence o f  benzoate, or even  
substrate, for that m atter, markedly reduces the am ount o f FAD  
exchanged , perhaps by inducing a conform ational change in the holoenzym e  
that prevents the re lease  o f FAD for exchange.
Although a number o f  enzym e inactivators have been produced for 
DAAO, severa l o f which have been  labelled  "suicide" inhibitors, m ost o f  
them  in a ctiv a te  the enzym e through the apoenzym e. Quite recen tly ,
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FIGURE 5.
The structure o f FAD.
C H o 0 P - 0 - P - 0 C H  
| OH OH \
(c h o h )3
CH„
OH OH
Me
9 a
T h e  I soa l l o xaz ine  Ring4a
Me
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how ever, A lston, Porter, and Bright (21) dem onstrated  the su icide  
in activation  o f  DAAO by 1 -ch lo ro -l-n itro eth a n e  at the N-5 position  o f the 
isoalloxazine nucleus o f  the FAD co fa cto r . Their research  noted that 
com p lete  in activation  occurred with nearly equal concentrations o f enzym e  
and ch loronitroethane, but that the enzym e could be p rotected  against 
in activation  by the inclusion o f  D -alanine in the m ixture. Furtherm ore, 
they id en tified  the m odified co fa cto r  as N (5)-acety l-red u ced  FAD, which  
resem bles the adduct previously dem onstrated  to be an in term ediate in the 
oxidation o f  nitroalkane substrates by DAAO. From th ese  data, then, it 
appears obvious that FAD, as w ell as the key am ino acid  residues outlined  
in the la st section , is present a t the a c tiv e  s ite  of the enzym e.
B. M ichaelis-M enten Theory and Enzym e Inhibition
1. M ichaelis-M enten Theory (22)
In a typ ica l, experim ental en zy m e-ca ta ly zed  reaction , the 
relationship  b etw een  the in itia l reaction  v e lo c ity  and the substrate  
concentration  can be expressed  by a hyperbolic curve that gradually leve ls  
o ff , indicating saturation o f the enzym e with substrate (Fig. 6 ). In order to  
represent the hyperbolic shape o f such a reaction  curve m athem atica lly , 
one uses the M ichaelis-M enten equation. The com ponents o f this equation  
are the maximum v e lo c ity  o f  the reaction  reached  at an in fin ite ly
high substrate concentration; Km, the substrate concentration  
corresponding to  one h a lf Vm ax, known as the M ichaelis-M enten constant; 
[s], the substrate concentration; and v0, the in itia l v e lo c ity  o f the 
reaction . The relationship  b etw een  Vmax and Km is also represented  in 
Fig. 6 .
The M ichaelis-M enten equation derives from the basic reaction
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FIGURE 6 .
The v vs. [ S] p lo t o f an enzym e ca ta lyzed  reaction . 
Kpn = 1/2 Vmax (23).
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involved in the form ation and breakdown o f  the enzym e-substrate com plex  
as the enzym e, E, c a ta ly z es  the conversion o f substrate, S, to  products, P. 
The reaction  is
where k^, k _ i, k2 , k_2 are the rate con stan ts for the resp ective  reaction s.
The derivation  o f the equation is fa irly  staightforw ard  when severa l 
assum ptions are m ade. F irst, the rate con stan t, k_2 , for the form ation o f 
the en zym e-su b stra te  com plex, ES, from the b aek-reaetion  o f E+P is 
assum ed to  be n eg lig ib le . Second, the reaction  system  is assum ed to  be in 
a stead y  s ta te , with the rate o f for nation and breakdown o f ES being 
equal. Using k in etic  theory to  represent the rates o f  form ation and 
dissocia tion  o f ES, and representing the to ta l enzym e concentration  as 
f e j ,  the con cen tration  o f  enzym e-substrate com plex as [E S], and the  
concentration  o f  substrate as fe ], one arrives at the fo llow ing result:
The rate lim iting  step  in Equation 1 is the form ation o f products from  
ES. Tile rate o f  this s tep  is the in itia l reaction  ve lo c ity , vQ, which is equal 
to k2 fiSSl. Solving for vQ and calling  the grouped rate constants Km, the  
M ichaelis-M enten constant, yields:
Finally, Vmax is defined  as the quantity k2 [EtJ> reaction  rate  
when a ll enzym e is present as ES, which g ives the M ichaelis-M enten
(1)
(2 )
[s ]  + (k«i + k2)/ki
k2
(3)
(Sl + K m
equation:
Bright and Porter (24) have shown that in DAAO ca ta lyzed  reactions  
the s te a d y -sta te  approach holds for high in itia l concentrations o f  substrate  
and O2 and low in itia l concentrations o f  products (im ino acid) and H2 O2 . 
Thus, M ichaelis-M enten theory can be used to  sim plify the m athem atically  
com plex DAAO rate law .
2. The Linew eaver-Burk Equation (22)
Km 1 1
l / Vo  --------------- , + ----------
y max [S ] Vmax 
This equation, known as the L ineweaver-Burk Equation, is o f  the linear 
form y = mx + b. With the equation in th is double recip roca l form , one can  
more readily s e e  its  value. P lotting  the reciproca l o f  the in itia l v e lo c ity  of 
an en zy m e-ca ta ly zed  reaction  against the substrate concentration  would 
produce a stra igh t line with a slope o f a y -in tercep t o f 1/Vmax,
and an x -in tercep t o f -1 /K m. In an inh ib itor-free system , the enzym e has a 
sp ec ific  Km value for a g iven  substrate. Comparison o f  K m values for 
d ifferen t substrates o f  that enzym e shows that the b etter  substrate has a 
low er Km value.
While rem ains constant for a sp ec if ic  enzym e and substrate, 
Vmax> on the other hand, depends upon the enzym e concentration . 
E xperim entally, the Linew eaver-Burk equation aids greatly  in the 
determ ination  o f  Vmax because in a p lot o f  v 0  vs. (Fig. 6 ), V ^ x  can  
only be obtained through extrapolation , while it can be obtained d irectly  
from the y -in tercep t o f a double reciprocal p lot made a t a constant 
enzym e concentration .
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3. Enzyme Inhibition (23)
The role o f  enzym e inhibitors in b io log ica l sy stem s is as im portant as 
that o f the enzym es th em selves. While enzym es speed m etabolic  reactions  
and rem arkably increase their e ff ic ie n c y , b io log ica l inhibitors are the 
regulators o f th ese  p rocesses. The th ree m ost com m on c la ss ifica tio n s  o f  
inhibitors are co m p etitiv e , n on com p etitive , and uncom p etitive inhibitors.
C om petitive Inhibition
A com p etitive  inhibitor d ecreases enzym e a c tiv ity  by com bining with 
the free enzym e so as to prevent substrate binding. As the nam e im plies, 
the inhibitor litera lly  com p etes w ith the substrate for the enzym e's a ctiv e  
s ite . In th is manner, the inhibitor and substrate are m utually exclu sive  
because only one can bind with the en zym e at a g iven  tim e. If the process  
is reversib le, re lea se  o f  the inhibitor can lead  to  en zym e-su b strate  binding. 
C om petitive inhibition can  occur in a variety  o f w ays, the s im p lest o f  
which is d ep icted  in Fig. 7. As for the k inetics, co m p etitiv e  inhibition  
increases the Km value because the enzym e now has le ss  a ff in ity  for the  
substrate, but Vmax rem ains the sam e because in fin ite ly  high 
concentrations o f  substrate o u t-com p ete  the inhibitor.
The equilibria for th is sch em e are:
E + S - - " z ^ E S  E -^E  + P
+
I
A
Ki
v
El
where Ks (= Ce ] [ S ] / [ E S ]  ) and Kj ( -  [E] [i] / [ S i ]  ) are the equilibrium
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FIGURE 7.
M odel o f com p etitive  inhibition. S and I are structurally  sim ilar and 
com p ete  for the sam e binding s ite  (23).
FIGURE 8 .
The v vs. [S ] p lot in the presence and absence o f a com p etitive  
inhibitor (23).
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FIGURE 9.
Double rec ip roca l p lot for the presence o f  severa l concentrations o f  
co m p etitiv e  inhibitor (23).
\’
S lo p e  =
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con stants for the g iven  reaction s, and kp is the rate constant for the  
breakdown o f ES into free  enzym e and products. The double reciprocal 
equation for this system  s t i l l  has a y -in tercep t o f  1 /V m ax, but the x -  
in tercep t is now “1 /K mapp, the apparent Km for the substrate, and the 
new slope is X mapp/^max* This apparent Km equals (1 + 5 ]/K j), 
which is the substrate concentration  that corresponds to 1/2 Vmax with  
inhibitor o f  the g iven  concentration  present. This y ields a double 
reciprocal equation o f
Km 1 1
1/v =_____  . (1 + [I] /Xj).______ + _______
^m ax [S ] Vmax
w here ft] is the inhibitor concentration . The value o f Kj is in terpreted  in 
much the sam e way as Km> i*e. the sm aller the value, the more e f fe c t iv e  
the inhibitor. The graphical representation  o f  the k in etics  o f com p etitive  
inhibition is shown in an in itia l v e lo c ity  vs. substrate concentration  plot 
(Fig. 8 ) and a double recip roca l p lot (Fig. 9).
N oncom petitive Inhibition
The distinguishing featu re o f  a noncom petitive inhibitor is its  ab ility  
to bind to  eith er the free  enzym e or to the en zym e-su b strate  com plex, and 
in addition, a substrate m olecule can bind to  the enzym e-inh ibitor com plex. 
These conditions produce a sch em e in which, unlike co m p etitiv e  inhibition, 
the substrate and inhibitor are not mutually exclu sive . As with  
co m p etitive  inhibition, n on com p etitive inhibition can occur in a variety  o f  
ways, the sim p lest o f  which is shown in Fig. 10. Binding o f the inhibitor to  
the enzym e induces a conform ational change in the enzym e that draws the 
ca ta ly tic  cen ter  o f the m olecular away from the substrate binding position ,
25
rendering the enzym e in active. If the inhibitor binding is reversib le, its  
release  can lead  to the final reaction  o f ES to  free enzym e and products, as 
shown in the equilibria below ,
Ks ^p
E + s — = ± ; e s  — >E + P
Ki
v
El + S:
K<
-ESI
Xi
where Ks = E i[S y  [ES] = [ e | [ s ] /  E si]a n d  Kj = [E ][l]/ |EI] = [ES]!# [E3I}
Exam ination o f a double reciprocal p lot o f  non com p etitive inhibition
revea ls  a decrease  in Vmax and a constant value (Fig. 11). Unlii<e 
com p etitive  inhibition, the enzym e cannot be saturated  w ith ex cess  
substrate to drive a ll the enzym e to  the productive ES form . Som e o f the  
enzym e w ill alw ays ex ist  as the in active  ESI com plex, and consequently, 
the maximum v e lo c ity  o f  the reaction  w ill be decreased . The Km value, 
how ever, w ill undergo no change during n on com p etitive inhibition because  
at any inhibitor concentration  the enzym e form s, E and El, which can  
com bine with the substrate possess equal a ff in it ie s  for the substrate. The 
appearance o f  this e f f e c t  is that le ss  to ta l enzym e is present, as can be
seen  from a p lot o f v vs. 6 ] (Fig. 12).
In a double recip roca l p lo t o f  n oncom petitive inhibition, both the  
slope and the y -in tercep t o f the inhibitor lines are increased com pared to  
the control line for which no inhibitor is present. Thus, the corresponding  
double reciprocal equation would be:
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FIGURE 10.
Model o f noncom petitive inhibition (23).
ESI
FIGURE 11.
D oable rec ip roca l p lot in the presence o f d ifferen t concentrations o f a 
n on com p etitive  inhibitor (23).
r+
I , lil\(.I+*r)S lo p e  =
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FIGURE 12.
The v vs. 60 p lot in the presence and absence o f a non com p etitive  
inhibitor (23).
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Km 1 1
1/v = ______ (1 + (j]/K i)._____ + ____ 1(1 + [I] /K i)
Vmax tSl Vmax
As is apparent, the increase in both the slope and y -in tercep t is by a factor  
of (1 + [ | /K i ) .
U ncom petitive Inhibition
While a co m p etitiv e  inhibitor binds only to the free  enzym e, and a 
n on com p etitive  inhibitor can bind the free enzym e or the en zym e-su b strate  
com plex , the third c la ss, ca lled  uncom petitive inhibitors, can bind only to  
the ES com plex. Fig. 13 show s a m odel o f this process, in which the  
inhibitor cannot bind with the enzym e until the ES com plex is form ed. 
Subsequent binding o f  I produces an in active  form by drawing the ca ta ly tic  
cen ter  o f the enzym e, C, aw ay from the substrate. R elease o f I can, 
how ever, lead to  the form ation o f  products, P, as shown in the equilibria:
Ks kp
E + S v  E S ------=—>  E + P
I
A
V
ESI
From the equilibria o f  these reactions, one can se e  that saturation  
with substrate would not drive a ll o f the enzym e to  the ES form because  
som e w ill alw ays be taken up as ESI. T herefore, one would ex p ect a 
d ecrea se  in Vmax* But this would also be accom panied  by a d ecrease  in the  
Km value because the uncom p etitive inhibitor draws som e o f the ES to ESI, 
causing a sh ift in the equilibrium  o f the reaction  E + S ES. Such a change
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FIGURE 13.
Model o f uncom petitive inhibition (23).
E n zym e E n zym e
Product
E n zym e
FIGURE 14.
Double rec ip roca l p lot for severa l concentrations of uncom petitive  
inhibitor (23).
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FIGURE 15.
The v vs. 6 ] p lot in the presence and absence o f an uncom petitive  
inhibitor.
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in equilibrium  g ives the appearance o f  a greater en zym e-su b strate a ffin ity , 
resu lting in a low er and, th erefore , b etter  value. These changes in 
and Vmax are readily apparent from the parallel lines o f the uncom petitive  
inhibitor double reciproca l p lot (Fig. 14) and from the v vs. Is! plot 
(Figure 15).
Although both Km and Vmax are a ltered  by an uncom petitive  
inhibitor, only the in tercep ts, and not the slopes, change in the double 
reciprocal p lot. C onsequently, the double reciprocal equation for  
n on com p etitive inhibition is
Km 1 1
l /v  = -------  .    (1 + [ l ] /K j )
+
^m ax [S ] Vmax 
Once again, the y -in tercep t changes by a factor  of (1 + [ll/K j).
Irreversible Inhibition; Suicide Inhibitors and A ffin ity  L abellers
The equilibria shown for the three modes o f inhibition im ply that the 
inhibition is reversib le . H ow ever, irreversib le inhibition can take p lace by 
any o f  th ese  three modes with the form ation o f a perm anent cova len t bond 
b etw een  the enzym e and inhibitor. The k in etic  e f f e c t  o f  such a process is 
to  reduce Vinax by perm anently elim inating  a portion o f  the enzym e from  
the reaction . Also, it is likely  that the e f fe c t iv e  en zym e-su b strate  a ffin ity  
will rem ain the sam e, leaving the Km value constant. These conditions 
would produce the sam e e f fe c t s  as a reversib le non com p etitive inhibitor, 
but the tw o can be distinguished experim entally  w ith a Vmax plot, which 
plots the maximum v e lo c ity  o f the reaction  against the to ta l enzym e  
concentration  (Fig. 18).
As shown by the Vmax p lot, a reversib le noncom petitive inhibitor 
would d ecrease  Vmax each  to ta l enzym e concentration , but any enzym e
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FIGURE 16.
P lot o f  Vmax vs. enzym e concentration  to  distinguish b etw een  a 
reversib le noncom petitive inhibitor and an irreversib le inhibitor (23).
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bound by inhibitor ean re lease  the inhibitor nnoleeule and go on to  form  
products. This situation  m erely reduces the rate o f the reaction , and 
th erefore , the Vmax p lot for a reversib le noncom petitive inhibitor w ill 
have a decreased  slope com pared to  that o f the control. On the other  
hand, an irreversib le inhibitor will com p lete ly  rem ove som e o f the enzym e  
from the reaction , producing a Vmax p lot w ith the sam e slope as the  
control. This line w ill in tersec t the x -ax is  a t a point equivalent to the 
am ount o f enzym e irreversibly bound by the inhibitor.
One sp ec ia l c la ss o f  irreversib le inhibitors is the su icide enzym e  
inhibitors. Som e o f the ch a ra cter istics  o f this group were exam ined in 
Section  1 (pp. 2-3), but som e other qualities o f these inhibitors warrant 
discussion here (6 ). One o f  the m ost im portant fea tu res o f a su icide  
inhibitor is its  irreversib le binding o f the enzym e, and to  determ ine this, 
one must estab lish  that the loss o f  enzym e a c t iv ity  is tim e-dependent. With 
tim e, more enzym e w ill be perm anently rem oved from the reaction , 
causing a gradually increasing loss o f a c tiv ity . If reversib le, the rate o f  
a c tiv ity  would d ecrease , but this d ecrease  would remain at a constant le v e l 
provided enough substrate was s t i l l  availab le. Although this method  
provides good ev id en ce for irreversib le in activation , probably the best 
m ethod is d ialysis. This process involves in activa tion  o f the enzym e and 
then d ialysis aga in st a concentration  gradient. If, a fter  exhaustive d ialysis, 
the enzym e is s t i l l  in activa ted , then the enzym e has been covalen tly  
m odified.
Another key to  su icide inhibition is the first order rate o f  
in activation  o f  the en zym e. This provides evidence that the inhibitor 
in a ctiv a tes  the enzym e w hile s t i l l  at the en zym eTs a c tiv e  s ite . A second  
order process, on the other hand, would ind icate conversion of a substrate
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m olecule to a more rea c tiv e  sp ec ies  which, upon re lease  from the a ctiv e  
s ite , could a ttack  the enzym e elsew h ere . For this reason, it is im portant 
to determ ine w hether the inhibition is a c tiv e  s ite  d irected  or not. This can  
be determ ined  by substrate or com p etitive  inhibitor p rotection  against 
in activation . If the rate o f  in activation  d ecreases with increasing  
substrate concentration  or in the presence o f a co m p etitiv e  inhibitor, like  
benzoic acid  for DAAO, then the inhibition is probably a c tiv e  s ite  d irected . 
These tw o types o f  m olecules w ill com p ete with the inhibitor for the a c tiv e  
s ite  o f the enzym e.
One final criterion  for su icide inhbition is that the rate of 
in activation  should be proportional to  the inhibitor concentration  a t low  
concentrations, but at high concentrations the in activation  is independent 
of concentration . This situation , known as saturation  k in etics, is 
ch aracter istic  o f  en zym e-su b strate rea c tiv ity . Thus, if  the inhibitor 
behaves like the en zym e’s norm al substrate, conditions should be right for 
su icide inactivation  to  occur.
Another im portant group o f  irreversib le enzym e inhibitors is the 
a ffin ity  labels. While many o f the ch aracter istics  o f th is group are the  
sam e as those o f  the su icide inhibitors, the main d ifferen ce  is a general 
lack  o f  sp e c if ic ity  for any one particular enzym e. The design o f an a ffin ity  
lab el generally  incorporates a rea ctiv e  functionality  in to  a m olecule that 
structurally  and e lec tro n ica lly  resem bles the en zym e’s natural substrate. 
These s im ilarities  to  a physio log ica l substrate w ill enhance the probability  
o f ch em ica l r ea c tiv ity  at the a c tiv e  s ite . H ow ever, b ecause o f  the highly 
reactive  functional group on an a ffin ity  label, it is not o f much use in v ivo . 
Their main use in v itro is to  allow  the elucidation  o f many o f the amino 
acid  residues a t the a c tiv e  s ite .
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C. Scope o f R esearch
Although, in the long run, the goal o f  this project would be the 
possib le developm ent o f a su icide enzym e in activator to  determ ine the 
p hysio logical function  o f  DAAO, this research  approaches that goal by 
using a ffin ity  labelling  agents to understand more about the structure and 
am ino acid  con ten t o f  the a c tiv e  s ite  o f DAAO. The prelim inary steps in 
th is research  w ere taken by Warren K oontz and Thomas Wong in 1982-83. 
Two im portant considerations w ere that a p oten tia l irreversib le inhibitor o f  
DAAO should resem ble natural substrates for the enzym e by fittin g  into  
the a c tiv e  s ite  g eom etr ica lly  and e lectron ica lly ; and that because  
nucleophilic a ttack  is a com m on process in enzym e a c tiv e  s ite  chem istry , 
the design o f  an inhibitor should allow  such an a ttack .
K oontz and Wong began w ith the croton ic acids (e is -  and trans-2 -  
butenoic acids), which, as reported by Fonda and Anderson, have re la tiv e ly  
low  Kj values as co m p etitive  inhibitors o f  DAAO (10“  ^ -  10“4) (25). These 
m olecu les, th erefore , f it  the a c tiv e  s ite  o f DAAO and react quite readily. 
Substitution  o f the term inal (m ethyl) carbon with a halogen like chlorine  
produces the c is -  and trans-3 -ch loroacry lic  acids ((Z)- and (E )-3- 
chloropropenoic acids), y ield ing a sp ec ies  with chlorine as a good leaving  
group and which would thus be open to  nucleophilic a ttack .
This research  first expands the ser ies  o f compounds in vestiga ted  by 
testin g  the inhibitory qualities o f  the p o ten tia l a ffin ity  labels c is -  and 
tran s-3-brom oacrylic acid  ((Z)- and (E)-3-brom opropenoic acid) and 
dibrom om aleic acid  (cis-2 ,3-d ibrom obutened io ic acid). The brom oacrylics  
were chosen for study on the assum ption that, because bromine is a b etter  
leaving  group than chlorine, they should be more potent inhibitors o f D AAO 
than the ch loroacrylics. D ibrom om aleic acid  allow s a com parison o f single
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and double substitu en ts o f  bromo and carboxyl groups. Second, the  
m echanism  o f  in activation  o f  DAAO by one o f  th ese  m olecules, trans-3 -  
brom oacrylic acid , was studied in depth to  d eterm ine if , indeed, 
irreversib le in activation  did take p lace . With such a strong leaving group 
as brom ine, one could ex p ect th is m olecu le to undergo a ttack  by one o f  the 
nucleophilic am ino acid  residues already known to  ex ist  at the a c tiv e  s ite  
or by FAD, which can a c t as a good nucleophile in its  reduced s ta te .
CHAPTER 2 
EXPERIMENTAL
A. M aterials
1. Enzym es and Subtrate. D -am ino acid  oxidase was purchased from  
Sigm a C hem ical Co.; FAD from  Eastman Kodak Co.; C ata lase from ICN 
P harm aceuticals, Inc.; and D -(-)-a -p h en y lg lyein e from Aldrich C hem ical 
Co.
2. Inhibitors. Trans-3-b rom oacry lic  acid  and cis-3 -b rom oacry lic  acid  
w ere syn th esized  by the m ethod o f Weir, e t al. (25)(see .Methods for 
syn theses). D ibrom om aleic acid , tcans-3-ch loroacrylic  acid , and c is -3 -  
ch loroacrylic acid  w ere a ll purchased from Aldrich C hem ical Co. B enzoic  
acid  was purchased from Fisher S c ien tific  Company. See Fig. 17 for 
structures o f a ll inhibitors.
3. R eagents for Syntheses. T rans-3-B rom oacrylic Acid. Propiolic  
acid  and hydrobromic acid  w ere both purchased from Aldrich C hem ical Co.
C is-3-B rom oacrylic Acid. Propiolic acid  and hydrobrom ic acid  were 
purchased from Aldrich, cupric brom ide was purchased from Allied  
C hem ical C o., and sodium su lfite  was purchased from Fisher.
A ll so lven ts were com m ercia lly  available reagent grade m aterials.
4. B uffers. Sodium pyrophosphate was purchased from Fisher 
S c ien tific  and also from -J.T. Baker C hem ical Co. Potassium  Brom ide was 
purchased from Fisher S c ie n tif ic . B uffers were standardized with 8 N HC1.
B. Instrum ents
Enzym e assays w ere conducted on a Beckm an ACTA 
Spectrophotom eter, solutions w ere kept at 37°C  during assays in a 
G C A /Precision  tem perature bath, and the pH o f  buffers was standardized  
with a Fisher A ecum et pH m eter.
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FIGURE 17.
S tructures o f  inhibitors: a) tra n s-3-brom oacrylic acid  b) c is -3 -  
brom oacrylic acid  c) tran s-3-ch loroacry lic  acid  d) c is-3 -ch loroacry lic  
acid  e) dibrom om aleic acid .
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C. Methods
1. Synthesis
T rans-3-3rom oacrylic Acid (26).
3.7 g Propiolic acid  was added drop wise to 20 ml o f 48% aqueous 
hydrobromic acid  and the solution was boiled under a reflux condenser for 
1.5 hours. When the solution  was cooled  in an ice  bath, the acid  
crysta llized  from solution  and was co llec ted  by Buchner filtra tion  and air 
dried. The crysta ls  were purified by charcoal trea tm en t and 
reerysta lliza tion  from hot ligroine. These crysta ls had a m elting point o f 
115 -  117 .5°C  (lit. 121°C ) (27). The structure was verified  by proton- 
NMR.
C is-3-B rom oacrylic Acid (26).
Cuprous brom ide was prepared from cupric brom ide and sodium  
su lfite  (28). Propiolic acid  (8.9 g) was added dropwise over 1 hour to  a 
stirred solu tion  o f  1.1 g  cuprous bromide in 22.5 ml o f 48% aqueous 
hydrobrom ic acid  that was cooled  to  1 -  5°C  in an ice  bath. The reaction  
m ixture was stored  overnight a t -8 °C . The m ixture was warmed to  room  
tem perature and the acid  was ex tra c ted  with severa l portions o f ether (3 x 
50 ml) and dried with anhydrous magnesium su lfa te . A fter filtration , the 
so lven t was evaporated and the crysta ls w ere purified by charcoal 
trea tm en t and reery sta lliza tio n  from hot ligroine. The m elting point o f  
th ese  crysta ls  was 60-62°C  (lit. 60.5 -  62). The structure was again  
verified  by proton-NM R.
2. Preparation o f Stock Solutions
Stock solutions o f  enzym e, substrate, and buffer were prepared as 
shown in Table 3 for a ll k in etic  stud ies ex cep t the reduced FAD study. 
Stock solutions o f  inhibitors varied in concentration  depending on the type
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TABLE 3.
Stock solutions for k in etics stud ies.
Compound Composi tion Concentration
Buffer: Sodium 
Pyrophosphate
2 3 .6 9 g / l000 ml H20 5.3 x 10"2 M
pH = 8.3
D-( - )-a-pheny1- 
glyci  ne
.0500g/50 ml buffer 6.52 x 1 0 '3 M
D-Amino Acid 
Oxidase
.1200g/10 ml buffer 3.05 x 10"4 M
A
Flavin Adenine 
Di nucleotide
.0078g/40 ml buffer 2.48 x 10"4 M
r
DAAO + FAD 50 ml solution [DAAO] = 
[FAD] =
6.10 x 10”3 M 
1.99 x 10'4 M
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of study perform ed, and they , th erefore , w ill not be reported here. The 
sodium pyrophosphate buffer was standardized to  pH 8.3 with 3N HC1 and 
a ll solutions w ere made w ith th is bu ffer. All solutions w ere stored  at 
approxim ately 4°C  in darkness, and enzym e and substrate solutions were 
not kept longer than 5 days because o f  lo ss  o f a c tiv ity .
3. .Assays o f E nzym atic A ctiv ity
The procedure for assaying enzym e a c tiv ity  involves the 
spectrop h otom etric  m easurem ent o f ca ta ly sis  o f D -phenylglycine to  
benzoylform ic acid  by DAAO at 252 nm, as described by Fonda and 
Anderson (29). The substrate D -phenylglycine was chosen because o f its 
ch a ra cter istic  sp ectra l change upon ca ta ly sis  to  benzoylform ic acid , which 
can be attributed  to  the keto  group conjugated with the arom atic ring. 
This sp ectra l change occurs at a maximum w avelength  o f  252 nm, and 
th erefore , the increase in absorbance with tim e at this w avelength  is an 
a ccu rate  m easure o f  the progress o f  the c a ta ly tic  reaction .
Solutions for each  assay w ere m aintained in volum etric flasks in a 
constant tem perature bath at 37°C , which is the optim um  tem perature for 
DAAO as w ell as human body tem perature. B ecause the enzym e solution  
lo ses sign ifican t a c t iv ity  a fter  sev era l hours at 37°C , only the am ount o f  
solution  needed for a particular assay was kept at this tem perature, and 
any unused enzym e solution  was thrown out a fter  the assay . As an 
additional sa fe ty  m easure, the en zym e solution was wrapped in aluminum  
fo il because o f  light sen sitiv ity  o f  FAD.
E nzym atic a c tiv ity  was assayed  by placing the appropriate 
concentrations o f buffer, enzym e, substrate, and inhibitor into a 3 ml 
reaction  c e l l  and m easuring the change in absorbance with tim e at 252 nm 
w hile the reaction  c e ll  was kept in a heating  block at 37°C  in the
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spectrophotom eter. During the assay , the re feren ce  energy was 
m aintained au tom atica lly  a t approxim ately 790 vo lts, and the slit  width o f  
the spectrophotom eter was usually kept a t 0.15m m . H ow ever, with  
inhibitors w hich absorbed strongly  at 252 nm, a re feren ce  ce ll with an 
equal concentration  o f inhibitor could be p laced  in the referen ce  
com partm ent o f the instrum ent. While this reduced the am ount o f  "noise" 
in the p lots, it required an increased s lit  width o f  as large as 8.0 mm at 
tim es.
3y  program m ing the spectrophotom eter for sp ec if ic  absorbance and 
tim e sca les , typ ica lly  0.5 inch/m in and 2 absorbance units fu ll sca le , the 
in itia l v e lo c ity  o f the reaction  could be m easured in units of 
A absorbance/m inute. The reaction  was usually follow ed  for ten  m inutes 
and the change in absorbance with tim e m easured along the m ost linear 
portion o f  the line. Beyond about ten  m inutes, how ever, a c tiv ity  begins to  
decrease  because o f  the gradual loss o f substrate due to  ca ta lysis  and the  
buildup o f hydrogen peroxide and b enzoylform ic acid  in inhibitory  
concentrations.
4. D eterm ination  o f Mode o f Inhibition
With each  inhibitor, Linew eaver-Burk p lots w ere made using the 
above sp ectrop h otom etric  technique to  determ ine the mode o f  inhibition. 
First, a control line for the p lot was made by perform ing assays at one 
enzym e con cen tration  and varying substrate concentrations. For each  
substrate concentration , the slope o f the line from the spectrophotom eter  
represents the in itia l v e lo c ity  o f  the reaction . The recip roca l o f each o f  
th ese  slopes, when p lo tted  against the reciprocal o f  the corresponding  
substrate concentration , y ields the control line o f  the Lineweaver-Burk  
plot.
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Using the sam e enzym e concentration  and severa l substrate  
concentrations, the sam e procedure was repeated  for each  o f severa l 
inhibitor concentrations. For each  inhibitor concentration , a stra ight liae  
was produced from which the mode o f  inhibition could be determ ined  when 
com pared with the control line.
Substrate concentrations for th ese  assays were varied b etw een  4.4 x 
10”4 M and 2.3 x 10”3 m in the reaction  c e ll because rdichaelis-M enten  
kin etics are b est observed when the in itia l substrate concentration  is c lose  
to  the su bstrate’s Km value for that particular en zym e. This would keep  
the enzym e operative at c lo se  to  1/2 Vm ax. These concentrations, then, 
are in the range o f the Km value for D -phenylglycine, which was found to 
range from 1 x 10"3 M to  3 x 10“  ^ M, , depending on the enzym e solution  
used. In addition, the inhibitor concentrations in the assays w ere varied  
depending upon the p oten cy  o f  the inhibitor.
5. Inhibitor Injections
A fter  determ ining the m ode o f  inhibition o f  the com pounds tested , 
inhibitor in jections w ere perform ed to  determ ine whether or not the 
inhibition was tim e-dependent, a ch a ra cter istic  ind icative o f  an 
irreversib le inhibitor. This procedure proved quite valuable because  
severa l o f the inhibitors te s ted  in activa ted  the enzym e quite rapidly. For 
exam ple, 5.09 x 10”4 M trans-3-brom oacrylic acid  inhibited as much as 62% 
o f enzym e a c tiv ity  in the first 30 seconds a fte r  introduction o f  the  
inhibitor. The inhibitor in jection  technique fa c ilita ted  m easurem ents o f  
loss o f a c tiv ity  in order to  d eterm ine the subsequent ra tes o f  inactivation . 
As a control, inhibitor in jection s w ere also perform ed with benzoic acid , 
the c la ss ic  reversib le com p etitive  inhibitor o f DA AO, because w ith it 
DAAO should not show tim e-dependent loss o f a c tiv ity .
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Inhibitor in jections were perform ed by p ipetting the appropriate 
volum es o f  buffer, substrate, and en zym e into the reaction  ce ll. A ctiv ity  
was m easured for 5 m inutes to  d eterm ine 100% a c tiv ity  o f the m ixture at 
those concentrations. At the s e t  tim e, the chart drive was stopped, the 
c e ll  com partm ent opened, and the inhibitor in jected  with a 3 ml 
hypoderm ic syringe. U sually, e ith er 0.05 or 0.1 ml w ere in jected  to  
prevent ex cess iv e  dilution o f  the m ixture and thereby maintain  
approxim ately the sam e concentrations o f enzym e and substrate in the  
c e ll. As m entioned earlier , to  prevent "noise" in the p lot when the  
inhibitor absorbs strongly  a t 252 nm, a re feren ce  c e ll with an equal 
con cen tration  o f  inhibitor was p laced  in the referen ce  com partm ent 
im m ed iately  prior to  the in jection .
The am ount o f  tim e required for in jection  o f  the inhibitor and 
thorough m ixing o f  the solu tion  was usually just under 30 seconds. Once 
the p lot was resum ed, a c t iv ity  was m easured for another 3 to  12 m inutes 
until linearity  was regained. If the inhibition is irreversib le one should see  
a gradual curving o f  the line to  a shallo wer slope, ind icating a gradual loss  
o f a c t iv ity . If, a fte r  linearity  is regained, the line begins to curve again, 
this is probably a resu lt o f lo ss o f  substrate and should not be a ttrib u ted  to  
the inhibitor.
These p lots w ere analyzed  in the sam e manner as the L inew eaver- 
Burk p lots, ex ce p t that slopes corresponding to  the change in a c t iv ity  with  
tim e w ere m easured by taking tangents to the curve at sp e c if ic  tim es. 
P ercen t a c t iv it ie s  w ere then ca lcu la ted  using the control as 100% a ctiv ity . 
In this manner, the rate o f  inhibition could be m easured to  make 
com parisons b etw een  d ifferen t inhibitors.
While inhibitor in jections w ere a very im portant technique in this
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project and quite reliab le, one must note severa l im portant considerations. 
First, because the in activation  by som e o f the more p oten t inhibitors 
occurs so rapidly, the absorbance sca le  o f  the sp ectrophotom eter was se t  
at 1 absorbance unit fu ll sca le  to broaden the curves and, therefore, allow  
more accu rate  p lacem ent o f  tan gen ts to the curve. As m entioned earlier, 
ex ce ss iv e  dilution o f the reaction  m ixture must be avoided by using sm all 
volum es o f inhibitor, and th erefore , stock  inhibitor solutions must be made 
appropriately. In addition, the procedure works b est if  a poten t inhibitor is 
used because a strongly inhibited enzym e w ill conserve enough substrate to  
m aintain a stead y  s ta te  o f the en zym e-su b strate  com plex over most o f the 
reaction  period. With a weak inhibitor another procedure can be used in 
which a separate control line is made by in jecting  the sam e volum e of 
buffer as inhibitor. This p lot w ill show the d ecrease in a c tiv ity  with tim e  
due only to  lo ss o f  substrate by form ation  o f products. P lots for each  of 
severa l inhibitor concentrations are made as b efore, but when analyzing  
data, one m ust make tangents to  both the control and inhibitor lines. The 
slope m easured for each  given  tim e on the control line is designated  10096 
a c tiv ity  for the corresponding tim e on the inhibitor line. Although this 
m ethod is a valid  m eans o f showing the e f f e c t s  caused by the inhibitor 
alone, a more reliab le procedure is m erely to  te s t  higher concentrations o f  
the inhibitor for which it  w ill be more p oten t. This a llow s one to see  more 
shutdown o f  the enzym e before too  great a loss o f  substrate occurs.
6. B enzoate P rotection
As sta ted  in C hapter 1, S ection  2 (14), an inhibitor can be shown to  be 
a ctiv e  s ite  d irected  if  the presence o f  benzoic acid  in the reaction  m ixture 
dim inishes the am ount o f in activation  o f  the enzym e by the p oten tia l 
irreversib le inhibitor. The procedure for this te s t  was to p ip ette
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appropriate concentrations o f  buffer, enzym e, substrate, and benzoic acid  
in to the reaction  c e ll and to  make a 10 096 control line as before. At the 
se t  tim e, the c e l l  com partm ent was opened and the correct amount o f  
inhibitor in jected . Sm all enough concentrations o f b en zoate  w ere required  
to prevent ex ce ss iv e  in activation  o f the enzym e by b en zoate alone or else  
no curvature could be observed a fter  the in jection . The am ount of 
in activation  in the p resence o f  benzoate could then be com pared to  the 
am ount o f in activation  by the sam e concentration  o f inhibitor without 
benzoate present. If the in activa tion  is le ss  w ith b en zoate, then  
presum ably the inhibition is a c tiv e  s ite  d irected .
7. R ate Order and R ate C onstant D eterm ination
D eterm ination  o f the order o f the reaction  o f inhibitor and enzym e is 
im portant to  provide inform ation as to  w hether the inhibitor it s e lf  or a 
m odified form o f the inhibitor in a ctiv a tes  the enzym e (6). Laidler (30) 
provides a m ethod for determ ining the order o f a reaction  in which the  
logarithm  o f the in itia l rate o f the reaction  is p lo tted  against the logarithm  
o f the in itia l concentration . The slope o f  the corresponding line is equal to  
the order o f the reaction . The procedure for th is m ethod began with  
inhibitor in jections a t severa l d ifferen t inhibitor concentrations. 3 y  taking  
the slope o f the region o f the p lot a fter  linearity  was regained to  be the 
in itia l rate o f  the reaction , which is essen tia lly  the procedure for in itia l 
rate determ ination  in the Lineweaver-Burk plot, the order o f the reaction  
could readily be determ ined.
A first-order reaction  im plies that the inhibitor m olecule it s e lf  is 
m odifying the enzym e, w hereas a second-order rate o f inactivation  
su ggests that a m odified  form o f  the inhibitor is released  by the enzyrne 
and in this form inhibits an enzym e m olecule. H ow ever, while it seem s
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likely  that one should se e  a reaction  that is pseudo-first-order in enzym e  
because o f  the ex ce ss iv e ly  high concentrations o f inhibitor that w ere used, 
the reaction  order with resp ect to  the inhibitor appears to  be som ew hat 
more d ifficu lt to  d eterm ine. While som e enzym e m olecules may be 
co m p lete ly  in activa ted  by the inhibitor, others may be only partially  
in activa ted , while s t ill  others may rem ain com p lete ly  u n affected . Thus, 
one may not see  in tegral values for the order o f the inhibition o f  DAAO. 
So, w hile th is m ethod may not provide precise q u antita tive values o f  
reaction  orders, it  does help m aintain con sisten cy  in the ca lcu la tion  o f  rate  
constants for the rates of inhibition.
Once the order o f the reaction  has been determ ined, rate constants  
could be ca lcu la ted  so that com parisons could be made am ong the d ifferen t  
inhibitors. These ca lcu lation s w ere perform ed for a first-order reaction  by 
p lottin g  the logarithm  o f  rem aining a c t iv ity  (from inhibitor injections) 
against tim e. L inearity o f such a p lo t also ind icates that the reaction  is 
first-order, and the slope o f th is line is the rate constant o f  the reaction . 
If the reaction  was determ ined  to  be second-order, then a p lot o f the 
rec ip roca l o f rem aining a c t iv ity  against tim e should be linear, again with a 
slope equal to the rate constant o f  the reaction . Com parisons were then  
made b etw een  c is  and trans com pounds, ch loro- and brom o-substituted  
com pounds, and m ono- and d isubstitu ted  compounds. The concentration  o f  
inhibitor used had to  be considered in these com parisons, for although a ll 
in jections were conducted  a t the sam e enzym e and substrate  
concentrations, inhibitor con cen trations had to  be increased for the weaker 
inhibitors for the reasons described  in Section  5.
8. Survey o f Trans-3-B rom oacrylic  Acid Inhibition and Incubation of 
Enzym e, Substrate, and Inhibitor.
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K oontz and Wong had dem onstrated  that inhibition o f DAAO by m ost 
halo-v inylic  acids did not occur without the p resen ce o f substrate. It was 
b elieved  that substrate was required to  induce a change in the enzym e  
which would allow  the inhibitor to  then in activa te  the enzym e. 
S p ec ifica lly , upon perform ing one c a ta ly tic  reaction  on a m olecule o f  
substrate, the FAD co factor  o f the enzym e would then be in its reduced  
form . In th is s ta te , FAD can a c t as a good nucleophile. If the enzym e  
m olecule encounters a m olecule o f inhibitor before becom ing reoxid ized , 
nucleophilic a ttack , and thus, inactivation , can take p lace .
In order to  test this theory, a survey o f the inhibition of DAAO by 
trans-3-brom oacrylic  acid  was conducted by testin g  severa l concentrations  
of inhibitor w ith a se t concentration  o f  DAAO and D -phenylglyeine. The 
purpose o f  this te s t  was to  find the appropriate concentration  o f inhibitor 
to  use in an incubation o f  en zym e, substrate, and inhibitor togeth er. Too 
weak a concentration  o f  inhibitor would allow  the buildup o f  too  much 
product, benzoylform ic acid . In addition, too  strong an inhibitor  
concentration  could cause denaturation o f  the protein . Ideally, a
sa tis fa c to ry  inhibitor concentration  would be one that would, during an 
assay o f  in itia l enzym e a c tiv ity  over a 10 m inute period, possibly show  
som e tim e-dependent loss o f  a c tiv ity , like in an inhibitor in jection .
A fter  se lec tio n  o f  a workable inhibitor concentration , the incubation  
was conducted by ;nixing the appropriate concentrations o f  enzym e, 
substrate, buffer, and ca ta la se  in a 50 ml erlenm eyer flask . A ctiv ity  o f  
this con trol m ixture was assayed, and again a fte r  the addition o f the  
appropriate amount o f inhibitor, in both cases by taking 3 ml aliquots o f  
solution  and assaying spectropho to  m etrically . The la tter  assay was 
designated  tim e 0. Incubation was conducted at 37°C  with the solution
49
exposed to  the air. A fter 1 hoar, another 3 ml aliquot o f the solution  was 
assayed. It was believed  that over this am ount o f tim e the presence of 
both substrate and inhibitor would com bine to  com p lete ly  in activa te  the  
enzym e. If a fter  one hour no a c tiv ity  rem ained, the appropriate amount o f  
dry D -phenylglycine was added to  the solution , as lack o f a c tiv ity  could  
m erely im ply lack o f  substrate rem aining a fter  one hour. By com p lete ly  
in activatin g  the en zym e in this w ay, it was hoped that other techniques  
such as proteolysis could be used to  id en tify  the in activa ted  com plex a fter  
separation  by liquid chrom atography or g e l filtration .
9. D ialysis
Exhaustive d ialysis o f  DAAO in activa ted  by trans-3-brom oacrylio  
acid  was conducted to  provide more ev idence as to  w hether the  
in activation  by this inhibitor was irreversib le. If, a fter  exhaustive dialysis, 
the enzym e rem ains in activa ted , presum ably a strong covalen t bond has 
form ed b etw een  enzym e and inhibitor.
D ialysis tubing o f  approxim ately 1 inch width was cu t into 50 cm  
lengths and boiled in deion ized  w ater for 30 m inutes with about 2g 
eth y len ed ia m in etetra a ce tic  acid  to rem ove any im purities that may have 
been present. The w ater was drained, fresh  deion ized  w ater added, and 
boiled again for 30 m inutes. This process was repeated  once more, 
whereupon the tubing was ready for use. When tubing was stored , it was 
placed  in a large beaker o f  deionized  w ater at 0°C  with a sm all amount 
(severa l gram s) o f  sodium azide . B efore use, the w ater was boiled and 
changed three tim es as described previously.
D ialysis was conducted on tw o solutions, one control, one inhibitor. 
Originally, both solutions were 30 ml in volum e. The control was com posed  
o f enzym e, FAD, and ca ta la se  in 0.05 M sodium pyrophosphate buffer,
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w hile the other contained  the sam e concentrations o f  enzym e, FAD, and 
ca ta la se  in the sam e buffer, but it  was also 1.00 x 10“^m in trans-3 -  
brom oacrylic acid  and 1.54 x 10”3 m in substrate. See Table 4.
P re-dialysis a c tiv ity  o f  the control was assayed at tim e 0 by taking a 
6 ml aliquot o f the contro l solution  and adding 1.4 mg dry D -phenylglycine, 
making the aliquot 1.54 x 10”  ^ M in substrate. Part o f this aliquot was 
used to rinse the cu vet and the rem aining portion for an assay o f  the  
a c tiv ity  at 37°C , pH 8.3, and 252 nm. P re-d ia lysis a c tiv ity  o f  the inhibitor 
solution  was assayed  sim ply by taking an aliquot o f  the 30 ml solution  
im m ediately  a fter  mixing and assaying under the sam e conditions as the 
control.
Both solutions w ere incubated at 37°C  in darkness for 10.5 hours, in 
the ca se  o f the inhibitor m ixture to  allow  for com p lete  in activation  o f the  
enzym e as was done in the incubations w ith enzym e, substrate, and 
inhibitor in the la s t  section . P re-d ia lysis a c tiv ity  was again assayed  as 
above at tim e=10.5 h, ex ce p t that in the case  o f  the inhibitor m ixture, an 
additional 1.4 mg dry D -phenylglycine was added to  a 6 ml aliquot (1.54 x 
10“3 M in substrate) under the assum ption that any residual enzym e  
a c tiv ity  would have d ep leted  the substrate already present. In addition, 
spectra  o f  the tw o m ixtures w ere scanned from 550-225 nm to  determ ine  
w hether any bleaching o f the FAD spectrum  had taken p lace.
D ialysis was then conducted  by p lacing 10 ml o f each  o f the tw o  
solutions into d ialysis tubing and d ia lyzing each  against 1 liter  o f 0.5 M 
K Br/0.05 M sodium pyrophosphate for 24 hours at 0°C . The buffer  
solutions w ere changed a t the end o f this tim e and this was repeated  three  
more tim es for a to ta l o f 96 hours o f  d ialysis. The solutions were then  
dialyzed  against 1 liter  o f 0.05 M sodium pyrophosphate buffer for 24 hours
TABLE 4.
C ontents o f d ialysis solu tions.
C ontrol (30 ml sol'n.) 
[DAAO] = 4.07 x 10-6 M 
[F A D ] = 1.32 x 10-5 M 
buffer = 28 ml, 0.05 M 
ca ta la se  = 0.2 mg
Inhibitor (30 ml sol'n.)
[DAAO] = 4.07 x 10-6 M
[F A D ] = 1.32 xlO -5 M
[D-phenylglycine] = 1 .5 4 x 1 0 -3
[trans-3-brom oacrylic acid] = 
1.00 x 10-3 M
buffer = 2 0  ml, 0.05 M
ca ta la se  = 0.2 mg
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at 0°C  to rem ove any e x c e ss  sa lt. The volum es o f the tw o solutions were 
m easured follow ing dialysis and the protein was recon stitu ted  by adding 
enough dry FAD to  make the solutions again 1.32 x 1 0 ”5 ;y[ in FAD.
The solutions w ere then placed  in a tem perature bath at 37°C  for 15 
m inutes. A ctiv ity  was assayed  for both solutions by thoroughly mixing 0.7 
mg dry D -phenylglycine and 3.0 ml solution in a dry cu v et. A ctiv itie s  were 
com pared to  d eterm ine if  irreversib le in activation  o f  the enzym e had 
indeed taken p lace.
13. R eaction  o f R educed FAD with T rans-3-B rom oacrylic Acid
One o f the m ost in teresting  phenom ena encountered  thus far in the 
inhibition o f  DAAO by trans-3-brom oacrylic acid  is the need for the 
presence o f substrate for in activation  to  occur. To d eterm ine whether this 
was actu a lly  caused by the reaction  o f  the inhibitor w ith reduced FAD  
a fter  ca ta ly sis  o f substrate, a m ethod was devised  w hereby one could  
com pare the in activa tion  o f  normal DAAO and reduced DAAO (reduced  
FAD cofactor). For this procedure, the control and inhibitor runs were the  
sam e, each  consisting  o f tw o separate solutions, e x ce p t that the control 
runs w ere conducted  under norm al aerob ic conditions while the inhibitor 
runs w ere conducted  under a n itrogen atm osphere. One solution  o f  the 
control contained only enzym e (3.05 x 10“® M), substrate (1.65 x 10“® M) 
and buffer. The enzym e solution  for a ll o f th ese  runs was made equim olar 
in DAAO apoenzym e and FAD ex ce p t for the sm all am ount o f  FAD already  
present in the enzym e at purchase for stab ility . This was done to  prevent 
such a great e x c e ss  o f unbound FAD in solution, and no sign ificant 
d ifferen ce  in a c tiv ity  was observed. The other solution  o f  the control 
contained the sam e am ounts o f enzym e and substrate, but it was also 1.50  
x 10“4 M in trans-3-brom oacrylic acid , which is a 49-fo ld  molar excess  of
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inhibitor over enzym e. Both control solutions, with and w ithout inhibitor 
present, w ere assayed for a c tiv ity  just a fte r  m ixing. These assays were  
conducted  a t room tem perature (24°C ).
In order to  m aintain an ox y g en -free  n itrogen atm osphere for the  
inhibitor runs, a ll stock  solutions w ere first evacuated  using a w ater  
aspirator con n ected  to a hypoderm ic need le . All solutions w ere in 
erlenm eyer flasks and covered  w ith rubber serum b o ttle  stoppers. A fter  
evacuation , the solutions w ere flushed with n itrogen for at le a st  5 m inutes 
through an in let n eed le m aintained below  the surface o f  the solution. An 
o u tlet need le was m aintained above the surface and was partially  blocked  
to keep a p ositive  gas pressure inside the flask . The in let n eed le  was then  
held above the surface o f  the so lu tion  for an additional 1 or 2 m inutes. 
B efore transferring the appropriate am ounts o f the desired stock  solutions 
to  a stoppered, 3 ml quartz cu vet that had first been evacu ated  and then  
flushed with nitrogen, an em pty , stoppered  erlenm eyer was a lso  evacuated  
and filled  with n itrogen. The 3 ml hypoderm ic syringes that w ere used to  
transfer the stock  solutions to  the cu v ets  w ere inserted  into this flask  and 
filled  w ith nitrogen and em ptied  severa l tim es to  elim in ate  any air from  
within.
The inhibitor run w ithout inhibitor was conducted by transferring 0.5 
ml substrate solution, 0.1 ml en zym e solution, and 1.3 ml buffer solution to  
the n itrogen -filled  cu v et. The m ixture was flushed with nitrogen for 
another 1 or 2 m inutes and then allow ed  to  incubate 15 m inutes so a ll the  
enzym e would have tim e to  be reduced. The original enzym e, in its  
oxid ized  form , upon carrying out one oxidation o f a substrate m olecule  
would then be in its  reduced form . A fter the incubation, an additional 0.1 
ml buffer was in jected , and a fter  another 15 m inutes the serum cap was
54
rem oved, the solution  aerated  using a pasteur p ip ette , and the a c tiv ity  
assayed  im m ed iately  at 24°C  and 252 nm.
The inhibitor run with inhibitor present was carried out ex a ctly  as 
above ex ce p t that a fter  allow ing 15 m inutes for the enzym e to  be reduced,
0.1 ml inhibitor solution  was in jected  into the cu v et. The inhibitor and 
reduced FAD w ere allow ed to  rea c t for 15 m inutes and then the serum cap  
was rem oved, the m ixture aerated  thoroughly and then assayed  for 
a ctiv ity .
In theory, i f  trans-3-brom oacrylic  acid  w ere to  react with reduced  
FAD to inhibit DAAO, then one should see  a greater d ifferen ce  in 
a c tiv it ie s  b etw een  the tw o inhibitor runs where the inhibitor encounters  
only reduced FAD, than b etw een  the tw o control runs where reduced FAD  
is just beginning to  be produced upon in teraction  o f  substrate w ith DAAO 
and where any reduced enzym e has an equal or greater chance o f  
encountering a m olecu le o f  oxygen and being reoxid ized  as it does o f  
reactin g  with an inhibitor m olecule. One final te s t  o f this theory was to  
scan the spectrum  o f  the enzym e a fte r  in teraction  with substrate from  
550-250 nm to  look for b leaching o f the FAD spectrum . This would
ind icate conversion o f a ll FAD to  its  reduced form .
CHAPTER 3 
DATA AND DISCUSSION
A. Data
1. Double R eciprocal P lots
In a ll double reciprocal p lots, the concentration  o f  DAAO was 4.07 x 
10“6 M.
B enzoic Acid.
A double reciproal p lot using the com p etitive  inhibitor benzoic acid  
was produced to  becom e fam iliar with the techniques to  be used throughout 
the p roject. Run A was the control with no inhibitor present; = 1.35 x 
10"3 M; Run 3 , [ l ]  = 3.46 x 10“6 M; Run C, [ i ]  = 1.69 x 10"5 M. The value 
of Kj was ca lcu la ted  as 1.02 x 1 0 ”5 m, which agrees w ell w ith the value o f  
1.17 x 10“5 M reported by Fonda and Anderson (29). Substrate  
concentrations w ere varied b etw een  1.10 x 10-3 M and 4.41 x 10”4 M. This 
plot (Fig. 18) confirm s that the inhibition by b en zoate  is com p etitive .
Trans-3-B rom oacrylic  A cid.
Two double reciprocal p lots w ere constructed  for trans-3 -  
brom oacrylic acid; one a t low  inhibitor concentrations; the second at much 
higher concentrations. In the first, approxim ately the sam e concentrations  
of inhibitor as in the b en zoate  p lot were used, and the control run, Run A, 
had a K;T1 value o f  1.28 x 10~3 M. Substrate concentrations were again  
varied b etw een  1.10 x 10~3 M and 4.41 x 10”4 M. The double reciprocal 
plot (Fig. 19) appears very much like that o f a com p etitive  inhibitor, and an 
approxim ate K\ value was ca lcu la ted  as 1.4 x 10“5 M. Thus, DAAO appears 
to have roughly the sam e a ffin ity  for trans-3-brom oacrylie acid  as it does 
for b en zoate .
In the second  double reciprocal plot o f trans-3-brom oacrylic acid
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FIGURE 18.
Double rec ip roca l p lot for the inhibition o f DAAO by b enzoic acid .
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FIGURE 19.
Double rec ip roca l p lot for the inhibition o f  DAAO with low  
con cen trations o f  tran s-3-brom oacrylic acid.
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(Fig. 20), Km = 1.90 x 10"3 M; in Run B, p] = 1.27 x 10-4 M. Run c> [j] = 
2.53 x 10~4 ]yj. Run [j] = 9 . 0 4  x 10“4 M. D -phenylglycine concentrations  
varied from 4.41 x 10“4 M to 2.32 x 10~3 M. This p lot also appears to  
ind icate co m p etitive  inhibition, becom ing som ew hat non com p etitive at 
clo se  to  10“3 M. H ow ever, at th ese  higher concentrations, an approxim ate  
Kj value was ca lcu la ted  as 8.2 x 10“5 M.
C is-3-B rom oacrylic Acid.
In th is assay, the contro l run, Run A, had a Km value o f  1.64 x 10“3 
M. Inhibitor concentrations varied as follow s: Run B, 3.31 x 10“3 M; Run 
C, 6.61 x 10~3 M; Run D, 1.32 x 10“3 M. C oncentrations o f  substrate, D- 
phenylglycine, ranged from 4.41 x 10“4 M to  1.99 x 10“3 M. From the 
double-reciprocal p lot (Fig. 21), c is-3 -b rom oacrylic  acid  appears to  exhibit 
prim arily co m p etitiv e  behavior, ex ce p t at higher concentrations where it 
appears s ligh tly  n on com p etitive . A Kj value was ca lcu la ted  for the  
compound as a co m p etitiv e  inhibitor o f DAAO in the concentration  range 
o f 3 x 10“3 M to  6 x 10“3 M and found to be 4.5 x 10“3 M. This Kj value is 
sign ifican tly  higher than that o f e ith er  trans-3-brom oacrylic acid  or 
benzoic acid . Kj values that w ere low er by a fa cto r  o f about 103 were  
obtained for much low er concentrations o f the previous tw o inhibitors.
D ibrom om aleic Acid.
While the brom oacrylic acids seem  to  exh ib it som e m ixed mode o f  
com p etitiv e  and n on com p etitive  inhibition o f DAAO, dibrom om aleic acid  
displays a more readily apparent m ixture o f  noncom petitive and 
uncom petitive inhibition, as can be seen  from the double reciprocal plot 
(Fig. 22). In th is assay , the control run showed a Km value o f 2.90 x 10-3  
M; in Run 3 , [ l ] =  8.20 x lO"4 M; Run C, [i] = 1.23 x 10~3 M; Run D, DO =  
1.64 x 10“3 M. Substrate concentrations varied from 4.41 x 10“4 M to 2.10
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FIGURE 20.
Double reciproca l p lot for high concentrations o f t rans-3 -br omoa cry lie  
acid .
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FIGURE 21.
Double rec ip roca l p lot o f DAAO inhibition by cis-3 -brom oacrylic  acid .
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FIGURE 22.
Double recip roca l p lot o f DAAO inhibition by d ibrom om aleic acid .
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x 10-3 ^  No Kj was ca lcu la ted  for th is inhibitor because the mode o f  
inhibition was so poorly defined .
2. Inhibitor Injections and B enzoate P rotection
For a ll in jection  stu d ies, concentrations o f  D -phenylglycine and 
DAAO w ere 1.10 x 10“3 M and 4.07 x 10“® M, resp ec tiv e ly . Injections o f  
all inhibitors ex cep t benzoic acid  produced sign ifican t tim e dependent 
in activation  o f  DAAO, indicating that a ll behave irreversib ly. B enzoate  
p rotection  stud ies w ere perform ed a t [B en zo a te ] = 6.55 x 10“® M. This 
con cen tration  o f  benzoate is approxim ately equal to  that o f DAAO, but far 
le ss  than the inhibitor concentrations. Thus, even a sm all am ount of 
p rotection  against in activa tion  could ind icate a c tiv e  s ite  d irection  o f the 
inhibition. N ote: f illed  c irc le s  on in jection  p lots all ind icate benzoate
p rotection  curves.
B enzoic Acid.
Inhbitor concentrations for in jections o f benzo ic acid  were: Run A,[I] 
= 1.00 x 10”3 M; Run B, [ i ]  = 1.00 x 10“® M. A ctiv itie s  w ere reduced to  
25.6% and 63.1% for Runs A and B resp ectiv e ly . B enzoate show ed no tim e  
dependence in its  in activa tion  o f  DAAO, exhib iting a constant change in 
absorbance with tim e a fte r  thorough m ixing as shown in Fig. 23, as was to  
be ex p ected  o f a reversib le inhibitor.
Trans-3-B rom oacrylic Acid.
Injections o f this inhibitor were perform ed a t the follow ing  
concentrations: Run A, [ I] = 5.00 x 10“  ^ M; Run B, [ I ]  = 2.59 x 10“4 M; 
Run C, [I] = 1.25 x 10“4; Run D, [T] = 3.25 x 10“® M. Trem endous
in activa tion  was seen  a t a ll [I], with a c t iv ity  dropping as low  as 4% o f the 
original a fter  5.5 m inutes. From th ese  data, trans-3-brom oacrylic acid  
appears to be a stronger inhibitor o f  DAAO, contrad icting resu lts from the
63
FIGURE 23. 
Injections o f  B enzoic acid.
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double reciprocal p lots. There, the tw o inhibitors showed approxim ately
the sam e Kj value as co m p etitiv e  inhibitors o f the en zym e. Here, 1.00 x 10
“3M benzoate reduced enzym e a c tiv ity  to  only 25.6% o f its  original value,
while a le sser  concentration  o f trans-3-brom oacrylic acid  (5.00 x 10“4 W). 
cu t DAAO a c tiv ity  to  only 4% o f its  original value. B enzoate p rotection ,
Run A*, was te sted  a t [I] = 5.00 x 10”4 and showed 2.476 protection
against in activa tion  a fter  5.5 m inutes. See Fig. 24.
Trans-3-C hloroacrylic A cid.
In order to  make an accurate com parison o f  the b ron o /ch lo ro  
substituen t e f f e c t  in inhibitors o f DAAO, approxim ately the sam e 
concentrations o f inhibitors were used. C oncentrations were: Run A, DG = 
4.98 x 10“4 M; Run B, [i] = 2.50 x 10"4 M; and Run C, [ I] = 1.25 x 10"4 M. 
While not quite as potent an inhibitor as its  brom o-substituted  counterpart, 
trans-3 -ch loroacry lic  acid  is s t i l l  rather pow erful, cu ttin g  DAAO a ctiv ity  
to as l i t t le  as 20% a fter  only 5.5 m inutes at [ l ] =  4.98 x 10“4 M (Fig. 25). 
B en zoate p rotection , Run A*-, a t [ i ]  = 4.98 x 10-4  M yielded  12.3%
p rotection  again st in activation , which su ggests  a c tiv e  s ite  d irection  o f the  
inhibition.
C is-3-B rom oacrylic Acid.
Using the sam e concentrations o f inhibitor as in the la st tw o injection  
stud ies y ielded  very li t t le  in activation . C onsequently, inhibitor 
concentrations varied as fo llow s: Run A, [ l ] =  5.00 x 10“3 M; Run B, [I] = 
2.59 x 10“3 M; Run C, p] = 1.25 x 10~3 M. T hese concentrations provided  
a sign ifican tly  m easurable am ount o f inactivation , how ever, inactivation  
was much le ss  than w ith the tw o trans compounds; for at [fl = 5.00 x 10“3 
M, DAAO a c tiv ity  dropped to  52% of the control a c tiv ity  within 5.5 
m inutes (Fig. 26). A lthough the inhibitor c o n c e n tr a t io n [ i]=  5.00 x 10“3 M
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FIGURE 24.
Injections o f trans-3-brom oacrylic acid  and benzoate p rotection .
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FIGURE 25.
Injections o f tran s-3-ch loroacry lic  acid  and benzoate protection .
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FIGURE 26.
Injections o f  c is-3 -b rom oacry lic  acid  and benzoate p rotection .
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in the benzoate p rotection  study, Run A*, was greater than that o f  
b enzoate by a factor  o f a lm ost 10^, the benzoate provided 10.8% 
protection  against in activation . Thus, c is-3 -b rom oacrylic  acid  is probably 
also a c tiv e  s ite  d irected  in its  inhibition o f DAAO.
C is-3-C hloroacry lic  Acid.
As w ith the trans com pounds, a com parison could be m ade b etw een  
cis-3 -ch loroacry lic  acid  and cis-3 -b rom oacrylic  acid  by perform ing  
in jections at sim ilar concentrations o f the tw o inhibitors. Thus, the  
inhibitor concentrations w ere: Run A, [i] = 5.09 x 1 0 ”3 M; Run B, [fl = 2.50 
x 10”3 M; Run C, DQ = 1.25 x 10”3 m. This compound and its  brom o- 
counterpart appear to  behave very sim ilarly, for at [I] =5.00 x 10“  ^ M, 
approxim ately 54% a c tiv ity  rem ained a fte r  5.5 m inutes (Fig. 27) .  This 
value is quite sim ilar to  the 52% a c tiv ity  rem aining in the ca se  o f the c is -  
brom oacrylic acid. Again, the compound appears a c tiv e  s ite  d irected  in its  
inhibition, for b en zoate p ro tected  14.2% against in activation  at fi] = 5.00 
x 10”3 M (Run A*).
D ibrom om aleic Acid.
Initial in jection  stud ies with dibrom om aleic acid  w ere perform ed at 
the sam e [ ]  as w ith the tw o c is  acids. H ow ever, this compound exhib ited  
much greater  strength  as an inhibitor o f  DAAO,  and thus, the  
concentrations te sted  were the follow ing: Run A, C l] = 1.25 x 10"3 M; and 
Run B, Cl ]=  6.35 x 10“4 m. A t [ I] = 1.25 x 10“3 M, more inactivation  o f  
the enzym e was observed than at any concentration  o f the tw o cis  
com pounds as the inhibitor reduced enzym e a c tiv ity  to  43% after  5.5 
m inutes (Fig. 28). D ibrom om aleic acid  also showed the h ighest benzoate  
p rotection  (Run A*), for at [i] = 1.25 x 1 0 ”3 m, enzym e inactivation  
decreased  from 43.1% to  60.4% , yield ing 17.3% protection  by b en zoate.
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FIGURE 27.
Injections o f  c is-3 -ch loroacry lic  acid  and benzoate p rotection .
100
00
60
40(j 0 7 0
70
FIGURE 28.
Injections o f  d ibrom om aleic acid  and benzoate p rotection .
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These data su ggest that d ibrom om aleic acid  is also an a c tiv e  s ite  d irected  
inhibitor o f DAAO.
3. D eterm ination  o f  R eaction  Order
P lotting  log  rate vs. log  fr] for each  inhibitor concentration  used in 
the in jection  stud ies produced the lines shown in Fig. 29 for trans-3 -  
brom oacrylic acid  and trans-3 -ch loroacry lic  acid . The trans-3 -  
brom oacrylic acid  p lot, line A, had a slope o f 1 .1 , while that o f tran s-3 -  
ch loroacrylie acid , line B, was 0.6. Although neither o f  th ese  values is 
in tegral, in both cases the inhibition o f DAAO appears to  be predom inantly  
first-order.
The log  rate vs. log  [J p lots for the tw o c is  compounds and 
dibrom om aleic acid  appear in Fig. 30. D ibrom om aleic acid, A, exh ib ited  a 
slope o f  0.9; the c is-3 -ch lo ro a cry lic  acid  p lot, B, had a slope o f  0.4; and the  
cis-3-brornoacrylic acid  p lot, C, had a slope o f 0.03. The first o f these  
plots su ggests that d ibrom om aleic acid  inhibition o f DAAO is first-order. 
Som e error may be involved, how ever, sin ce only tw o concentrations were 
p lo tted . The c is-3 -ch loroacry lic  acid  plot could w ell ind icate , within  
experim ental error, that the inhibition is first-order. For c is -3 -  
brom oacrylic acid , a zeroth-order reaction  seem s highly unlikely, 
esp ecia lly  when one considers the data for a ll the other compounds. One 
would hardly ex p ect to  see  a compound with a structure so sim ilar to  the  
other inhibitors behave so d ifferen tly . Most im portant, though, is the fa c t  
that a ll reaction  orders w ere w ell below  2, suggesting no second-order  
a c tiv ity . T herefore, for c is-3 -b rom oacry lic  acid  and the other four 
inhibitors o f  DAAO, the reaction  order was determ ined to  be 1, and rate  
constants w ere ca lcu la ted  for first-order reaction s.
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FIGURE 29.
Log rate vs. log  [ i ]  p lot to determ ine reaction  order for trans-3 -  
brom oacrylic acid, A; and tran s-3-ch loroacrylic acid , B.
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FIGURE 30.
Log rate vs. log  [ I ]  p lot to determ ine reaction  order for dibrom om aleic  
acid , A; c is-3 -ch lo ro a cry lic  acid , B; and cis-3 -brom oacrylic  acid , C.
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4. D eterm ination  and Com parison o f R ate C onstants
As s ta ted  earlier , the rate constant o f a first-order reaction  can be 
determ ined  by p lotting  the logarithm  o f the percent a c t iv ity  rem aining  
against tim e. The slope o f  th is line is the rate constant o f the reaction . In 
this manner, rate con stan ts w ere ca lcu la ted  for a ll five inhibitors o f  DAAO  
using data from  the inhibitor in jections. A rate constant was ca lcu la ted  
for each  inhibitor concentration , so each  line on the first-order rate p lot 
corresponds to  a curve on the in jection  plot o f that inhibitor, with the  
excep tion  o f the benzoate p ro tection  line (sam e sym bols and le tte r s  used to  
d enote sam e concentrations). These first-order rate p lots are shown in Fig. 
31, trans-3-brom oacrylic acid; Fig. 32, trans-3-ch loroacry lic  acid; Fig. 33, 
cis-3-b rom oacrylic  acid; F ig. 34, c is-3 -ch loroacry lic  acid; and Fig. 35, 
dibrom om aleic acid .
The rate constants determ ined  from these slopes are shown in Table 
5, and the various com parisons b etw een  inhibitors are shown in Table 6. 
For m ost o f the com parisons the inhibitor concentrations, and th erefore  
the inh ib itor/enzym e ratios, w ere the sam e. This made a d irect 
com parison o f rate con stan ts possib le. H ow ever, when com paring one o f  
the trans compounds to  one o f the c is , for exam ple, a ratio  was se t  up to  
account for the d ifferen ce  in the inh ib itor/enzym e ratio . This step  was 
fa c ilita ted  by the fa c t  that the tw o concentrations being com pared usually  
d iffered  by a factor  o f 10.
From these data, one can order these five inhibitors o f  DAAO by 
strength  o f inhibition as fo llow s: t rans-3-brom oacrylic > trans-3 -
ch loroacrylic > dibrom om aleic > cis-3 -b rom oacrylic  >_ c is-3 -ch loroacry lic . 
These resu lts agree w ell with the original assum ption that the brom ovinylic 
acids would be b etter  inhibitors than the ch loro-substitu ted  acids by virtue 
o f brom ine as a b etter  leav in g  group. Also confirm ed here are the results
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FIGURE 31.
F irst-order rate p lo ts for trans-3-brom oacrvlic acid.
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FIGURE 32.
F irst-order rate p lots for trans-3-ch loroacrylic acid.
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FIGURE 33.
F irst-order rate p lo ts for cis-3-brom oacrylic  acid .
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FIGURE 34.
F irst-order rate p lots for cis-3 -ch loroacryIic  acid.
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FIGURE 35.
F irst-order rate p lo ts for dibrom om aleic acid .
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TABLE 5. 
First-order rate constants.
[ T r a n s - 3 - B r o m o a c r y l i c  A c i d ]  (M) k (min*■b [ I ] / C E ]
5 . 0 0  x 1 0 ' 4 
2 . 5 0  x 1 0 - 4
1 . 2 5  x 1 0 - 4
6 . 2 5  x TO' 5
1 . 2 6  x
1 . 2 6  x 
4 . 3 8  x 
2 . 6 7  x
0 1
°1
o *2
' 123 
61 
31 
15
[ T r a n s - 3 - C h l o r o a c r y l i c  A c i d ]  (M) k (min~ ) [ I J / C E]
4 . 9 8  x 10~4 
2 . 5 0  x 1 o ' ;  
1 . 2 5  x 10- 4
6.31 x 
4 . 0 9  x 
3 . 4 0  x
oil
O"2
123
61
31
[ C i s - 3 - B r o m o a c r y l i c  A c i d ]  (M) k ( m i n - ) [ I ] / [ E ]
5 . 0 0  x 10- ^ 
2 . 5 0  x 1 0 ' ^  
1 . 2 5  x 10 - J
2 . 8 0  x 
2 . 4 5  x 
1 . 4 0  x
°:2
S-2
1230
610
310
[ C i s - 3 - C h l o r o a c r y l i c  A c i d ]  (M) k ( mi n - ) [ I ] / [ E ]
5 . 0 0  x 10"?  
2 . 5 0  x 10"?  
1 . 2 5  x 1 0 " J
2 . 9 5  x 
1 . 5 0  x 
9 . 0 0  x
° : 2
S-3
1230
610
310
[ D i b r o m o m a l e i c  A c i d ]  (M) k ( mi n - ) rn/m
1 . 2 5  x 1 0 i  
6 . 3 5  x 10"4
3 . 4 5  x 
1 . 30  x °12 o *- 310160
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TABLE 6.
Various com parisons o f  first-order rate constants
1.  T r a n s - 3 - B r o m o a c r y l i c  Acid  v s .  T r a n s - 3 - C h l o r o a c r y l i c  Ac i d
[ I ] / [ E ]  kB(. ( m i n ' 1 ) kc l  ( mi n*1 ) kBr /' kCl
123 1 . 2 6  x 1 0 ' !  6 . 31  x 1 0 ' ?  2 . 0
61 1 . 2 6  x 1 0 ,  4 . 0 9  x 1 0 ' :  3 . 1
31 4 . 3 8  x 1 0 ' ^  3 . 4 0  x 1 0 ' ^  1 . 3
2.  C i s - 3 - B r o m o a c r y l i c  Acid v s .  C i s - 3 - C h l o r o a c r y l i c  Ac i d
- I  -1[IJ/[EJ kBr (min ) k^ (min ) kB r / k Cl
1230 2 . 8 0  x 10~2 2 . 9 5  x 10"?  0 . 9 5
610 2 . 4 5  x 1 0 ' ?  1 . 5 0  x 10"?  1 . 6
310 1.40 x 1 0 ' ^  9 . 0 0  x 10" 1 . 6
3 .  D i b r o m o m a l e i c  Ac i d  v s .  C i s - 3 - B r o m o a c r y l i c  Acid
[ I ] / [ E j  kgr ?  ( m i n ' 1 ) k g r  ( mi n - 1 ) kB r ? / k Br
310 3 . 4 5  x 10-2 1 . 4 0  x 1 0 ' 2 2 . 5
4.  D i b r o m o m a l e i c  Acid  v s .  Ci s - 3 - C h l o r o a c r y l i c  Acid
[ I ] / [ E ]  kBr? kci (mln ) kgr g/ k ci
310 3 . 4 5  x 10*2 9 . 0 0  x 10*3 3 . 8
82
TABLE 6. 
(continued)
5= T r a n s - 3 - B r o m o a c r y l i c  Acid  v s .  C i s - 3 - B r o m o a c r y l i c  Acid
m / [ E ]
123
61
31
k ,  (mi n“ 1) k. / k .t r a n s  v ' t r a n s  c i s
1 . 26  x 10
1 . 2 6  x 10 
4 . 3 8  x 10
-1
-1
- 2
45
51
31
CIS
2 . 8 0  x 
2 . 4 5  x 
1 . 4 0  x 10
10
10
- 2
- 2
- 2
[ I ] / [ E ]
1230
610
310
6.  T r a n s - 3 - C h i o r o a c r y l i c  Acid  v s .  C i s - 3 - C h l o r o a c r y l i c  Acid
[ I ] / [ E ]
123
61
31
“t r a n s
6.31 x 10 
4 . 0 9  x 10 
3 . 4 0  x 10
-2
-2
-2
^tra n s^ c is
21
37
38
c i s  ( m i n ' 1 ) [ I l / f E l
2 . 9 5  x 10 
1 . 5 0  x 10 
9 . 0 0  x 10
-2
-2
-3
1230
610
310
7.  T r a n s - 3 - C h l o r o a c r y l i c  Ac i d  vs .  Di b romomal e i c  Ac i d  
[!]/[£] k Ci (min""1) kr i / k
C ° r 2 kBr2 (rnin" 1}
31 3 . 4 0  x 10 - 2 9 . 9 3 . 4 5  x 10 -2 310
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obtained by Warren Koontz and Thomas Wong, nam ely, that the tran s-  
acry lic  acids are more poten t inhibitors o f  DAAO than the e is-a cry lic  
acids.
Their value o f  ^ trans/^cis “ f ° p the eh loroacrylic  com pares w ell w ith  
that reported here considering that their value was ca lcu la ted  from' 
second-order rate p lots rather than first.
5. Survey o f  Trans-3-B rom oacrylic Acid Inhibition and Incubations.
U nfortunately , a survey o f  severa l d ifferen t concentrations o f trans-  
3-brom oacrylic acid  fa iled  to  revea l one that s t i l l  showed any v isib le tim e-  
dependent lo ss o f  a c t iv ity  a fter  the severa l m inutes required to  mix the 
solutions and insert the cu v et in the sp ectrop h otom eter. Thus, the fairly  
low con cen tration  o f  1.24 x 10“® m was in itia lly  chosen for the incubations 
with substrate and en zym e. This concentration , how ever, proved to  be too  
low . A fter a one hour incubation, enough enzym e a c tiv ity  s t ill rem ained to  
allow  the buildup o f  a great deal o f benzoylform ic acid , causing the  
absorbance a t 252 nm to  be c lo se  to  2.0. Thus, the spectrophotom etric  
plots w ere nearly  unreadable due to  the "noise”. Using 1.25 x 10“4 ;y[ 
trans-3-brom oacrylic acid  grea tly  im proved th is d ifficu lty .
In addition  to  the above concentration  o f  inhibitor, the incubated  
solution  was 4.07 x 10“® M in DAAO, 1.32 x 10“® M in FAD, 1.54 x 10“® M 
in D -phenylglycine, and 0.006 m g/m l in ca ta la se . At tim e = 0, the presence  
o f the inhibitor cu t enzym e a c t iv ity  to 35.9% o f  the original. At tim e = 1 
hour, a c t iv ity  had dropped to  28.3%, apparently ind icating a sign ificant  
increase in in activa tion  by trans-3-brom oacrylic acid  w ith tim e. However, 
at tim e = 1.5 hours, a c t iv ity  had increased  sligh tly  to  29.1%. Som e o f the  
confusion over this s itu ation  was la ter  resolved  when Robin F oster, working 
with a sim ilar inhibitor, te s ted  the product o f the D A A O -D -phenylglycine
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reaction  and found it to  be a rather potent inhibitor o f DAAO. With 
ca ta la se  present, benzoylform ic acid  can build up in inhibitory  
con cen trations, and, as shown in Fig. 2, w ithout ca ta la se  present in the  
reaction  m ixture, this k eto  acid  product w ill r e a c t with hydrogen peroxide  
to  produce benzoic acid . Thus, it becam e evident that incubations over  
long periods with substrate presen t would produce som ew hat questionable  
resu lts because o f the buildup o f other inhibitors o f DAAO.
6. D ialysis
A volum e o f 10.0 ml was recovered  from the contro l d ialysis run and 
10.4 ml w ere recovered  from the inhibitor run. In both ea ses , 0.1 mg dry 
FAD was added to  make the solutions 1.32 x 10  ”5 M in FAD. Table 7 
sum m arizes the sp ectrop h otom etric  resu lts o f  the d ialysis o f DAAO  
in activa ted  by trans-3-brom oacrylic  acid . During incubation, the control 
a c tiv ity  dropped to  24% of its  startin g  a c tiv ity , while the inhibited enzym e  
only fe l l  to  74% o f its  original a c tiv ity . A fter d ialysis, the contro l showed  
alm ost no change in a c t iv ity , rem aining at 24% of the original. The 
inhibited enzym e, how ever, show ed a marked increase in a c tiv ity , 
exh ib iting over 300% o f its  original, inhibited a c tiv ity . In fa c t , the 
inhibited enzym e a fter  d ialysis show ed more a c t iv ity  than the control, both  
a fte r  incubation and a fter  d ia lysis.
These resu lts have tw o  im portant indications. F irst, it  seem s that 
because the inhibited enzym e is regained a great deal o f a c tiv ity , DAAO  
was reversib ly  in activa ted  by tran s-3-brom oacrylic acid . This was 
con sisten t with resu lts obtained by M elissa Moore for the inhibition o f  
DAAO by (E)-2-brom ocinnam ic acid . A fter 96 hours o f  d ialysis, m ost o f  
the a c t iv ity  o f the enzym e was resum ed, indicating either reversib ility  o f  
the inhibition or another p ossib ility . It was hypothesized  that the inhibitor
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Pre-dialysis (t=0) 
P re-dialysis (t=10.5h) 
P ost-d ia lysis
TABLE 7. 
R esults o f d ialysis.
Lnhibitor
C ontrol A ctiv ity  
(A A /m in )x l0 2
% o f  
t=0
A ctiv ity  % of  
(AA/m in)xl02 t=0
5.0 100% 0.54 100%
1.2 2496 0.40 7496
1.2 24% 1.8 333%
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could bind with the nucleophilic reduced FAD produced once the substrate  
has been oxid ized . This condition also  sa tis f ie s  the need for su bstrate in 
the reaction  m ixture, as was shown by Tom Wong. H ow ever, the scan  o f  
the FAD spectrum  a fter  the 10.5 hour incubation showed no b leaching of 
the inhibited enzym e. In fa c t , the only d ifferen ce  b etw een  the tw o spectra  
was a t 252 nm, due to  the am ount o f product a llow ed  to form by the  
residual a c tiv ity  o f the inhibited en zym e. This su ggests  no bond form ed  
betw een  reduced FAD and trans-3-brom oacrylic  acid . This hypothesis was 
te sted , and the resu lts are given  in the next sectio n .
Second, it appears that the inhibitor may lend som e sta b ility  to  the 
enzym e, for while the control lo st over 75% o f its  a c t iv ity  during 
incubation, probably due to  h ea t denaturation, the inhibited en zym e only  
lo s t  about 25% more a c t iv ity  than had been lo s t  through inhibition. In 
addition , a fter  d ialysis at 0°C , the inhibitor m ixture's a c t iv ity  jumped to  
over 1/3  the control's original (t=0) a c tiv ity , while the control exhib ited  
alm ost no change in a c t iv ity  a fte r  d ialysis. Thus, it seem s that the  
presence o f  inhibitor may help p ro tect against heat denaturation o f  DAAO, 
but th is may a lso  be caused by the presence o f substrate, because the  
control m ixture lacked  substrate as w ell as inhibitor. This possib ility  has 
som e support in the work o f  Tojo, e t  a l., who found that the rate o f  
dim erization  o f  DAAO was doubled by the presence o f  the inhibitor  
ben zoate . Apparently, the b en zoate  a cce lera te d  a conform ational change  
in the holoenzym e which was n ecessary  for d im erization  (31).
7. R eaction  o f Reduced FAD with Trans-3-B rom oacrylic Acid.
The sp ectrop h otom etric  resu lts o f  this study are sum m arized in Table
8. The a c tiv ity  of the control, under aerobic conditions, was reduced by 
about 75% in the presen ce o f inhibitor. T heoretica lly , the a c tiv ity  of the
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w ithout I 
with I
TABLE 8.
R esults o f reduced FAD study.
C ontrol A ctiv ities  
A/m in) x lp3
‘26.1
6.5
% o f  
original
100%
25.0%
Inhibitor 
A ctiv itie s  
(N 2) % of
(& A /m in)xlQ 3 original
12.8
3.5
100%
27.4%
inhibitor run, under a n itrogen  atm osphere, should be reduced by a greater  
am ount than this on ce exposed to  inhibitor if  trans-3-brom oacrylic acid  
actu ally  rea c ts  with reduced FAD. However, the enzym e under nitrogen  
retained  slightly  more a c t iv ity  than the control when exposed  to  inhibitor, 
contraindicating the im portance o f  reduced FAD in the in activation  o f  
DAAO.
In one ca se , when the enzym e and substrate under nitrogen were 
incubated for approxim ately tw o hours and the spectrum  sim ultaneously  
scanned to  look for b leaching o f the FAD spectrum , very l i t t le  change, if  
any, was noted. One would ex p ect the enzym e to  be reduced quite readily  
in the presence o f substrate, and under n itrogen, no reoxidation  should  
occur. H ow ever, even  though solutions were made equim olar in apoenzym e  
and FAD, DAAO was purchased from Sigm a C hem ical Co. w ith som e FAD  
already present. Thus, there may s t il l  have been an ex ce ss  o f FAD in the  
m ixture. B ecause no molar ab sorp tiv ities were ca lcu la ted  for the d ifferen t  
enzym e solutions in the region o f the FAD spectrum , sp e c if ic  am ounts of 
bleaching, if  it occurred, could not be determ ined.
B. D iscussion
Exam ination o f the L ineweaver-Burk p lo ts  for c is -  and trans-3 -  
brom oacrylic acids revea ls prim arily co m p etitive  inhibition. B ecause o f  
the sim ilarities b etw een  the brom oacrylics and the ch loroacrylics  
e lectro n ica lly  and geom etr ica lly , one would ex p ect the tw o groups to  
exhib it the sam e mode o f  inhibition of DAAO. H ow ever, Koontz and Wong 
reported  that the ch loroacrylics w ere non com p etitive inhibitors o f DAAO. 
Exam ination o f  their data shows that the ch loroacrylics are s ligh tly  mixed 
in their modes o f inhibition but appear to  behave quite sim ilarly to  the 
brom oacrylics. D ibrom om aleic acid , on the other hand, appears to  inhibit
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DAAO prim arily non com p etitively , with som e uncom petitive behavior at 
higher concentrations o f inhibitor.
R egardless o f their m odes o f  inhibition, a ll five o f these compounds 
appear to be irreversib ly in activa tin g  the enzym e, as suggested  by the  
tim e-dependent in activation  o f DAAO. These resu lts seem  reliab le when  
com pared with the benzoic acid  inhibitor in jections which showed tim e-  
independent in activa tion  o f DAAO. Although the resu lts o f d ialysis w ith  
t rans-3-br o moa cr yli c acid  could be in terpreted  to  show reversib le  
inhibition, recen t research  conducted  by Robin F oster in th is lab provides 
inform ation to  the contrary. Foster perform ed a dialysis experim ent 
id en tica l to  that described in this research , ex cep t that the inhibitor was 
(E)-2-brom ocinnam ic acid , and instead  o f testin g  a c t iv ity  a fter  a 96-hour 
dialysis, a c tiv ity  was te s te d  a fter  24 and 48 hours. A fter 24 hours o f  
d ialysis, she found that only 13% o f the control a c tiv ity  before d ia lysis was 
regained. In sharp con trast, a fte r  48 hours 85% o f a c tiv ity  had returned. 
A beles has s ta te d  that reversib ility  is determ ined  by "how much a c tiv ity  is 
regained a fte r  . . . d ialysis for 24 hours. This tends to  distinguish tigh tly  
bound inhibitors from th ose th at form a covalen t bond. If reversib le  
inhibition is involved, ca ta ly tic  a c t iv ity  w ill return a fter  these procedures."  
If the inhibition is through a covalen t bond, no a c tiv ity  should be regained  
(32). In th is ca se , because only 13% of the a c tiv ity  was regained a fte r  24 
hours, the inhibition could be irreversib le; how ever, the situation  appears 
som ew hat am biguous.
The benzoate protection  stud ies perform ed here ind icate that this 
in activa tion  occurs at the a c tiv e  s ite  o f the enzym e. This may be so even  
in the case  o f trans-3-brom oacrylic  acid , which show ed only a 2.4% 
d ecrease  in in activation  in the presence o f b en zoate. The re la tiv e ly  sm all
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concent ration o f  b en zoate , when com bined with high concentrations o f this 
ex trem ely  p oten t inhibitor could easily  lead to  a situation  in which the 
benzoate sim ply cannot com p ete with the irreversib le inhibitor for the  
a c tiv e  s ite  o f the enzym e due to  its  own reversib ility . The approxim ate  
ca lcu la ted  for trans-3-brom oacrylic acid  was a lm ost equal to  that o f  
benzoate. Thus, if  DAAO has an equal a ffin ity  for the tw o inhibitors, and 
with a much higher concentration  o f  trans-3-brom oacrylic  acid , the low  
protection  by b en zoa te  seem s understandable.
In addition, the lack o f rea c tiv ity  b etw een  trans-3-brom oacrylic acid  
and reduced FAD tinder a nitrogen atm osphere im plies inhibition at a 
nucleophilic, a c tiv e  s ite  am ino acid  residue rather than at FAD. These 
resu lts s t il l  provide no clear explanation  for the requirem ent o f substrate  
in the reaction  m ixture. The reduced FAD hypothesis sa tis fied  this  
requirem ent sim ply b ecause the presence o f substrate w ill crea te  this 
reduced co fa c to r . The p ossib ility  then arises o f a substrate-induced  
conform ational change in the apoenzym e which would expose the necessary  
nucleophilic am ino acid  residue, a llow ing a tta ck  on the inhibitor. This 
schem e, how ever, is rep resen ta tive  only o f uncom petitive inhibition, where 
the inhibitor can bind only w ith the en zym e-su b strate com plex. The 
brom oacrylics, found to  be m ainly com p etitive  inhibitors, would not sa tisfy  
this condition. Perhaps the need for substrate and possibly for 
n on com p etitive inhibition could explain the mixed modes o f inactivation  of  
DAAO. Having ruled out the possib ility  o f reduced FAD actin g  as the  
nucleophile, one can look to  the work o f Swenson and Ronchi, e t  a l., (14) to  
find a nucleophilic amino acid  residue. Three residues, tyrosine, lysine, and 
histid ine, are a ll believed  to lie  at the a c t iv e  site  and could a ll a c t  as good 
nucleophiles.
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Exam ination o f the possible m echanism s for the inhibition o f DAAO  
by th ese  halo-v inylic acids produces a likely  schem e in which just such an 
am ino acid residue could prom ote inhibition. Upon positioning o f  the 
inhibitor at the a c tiv e  s ite , the inhibitor would undergo nucleophilic a ttack  
by the enzym e to  produce a cova len tly  m odified enzym e m olecu le. This 
schem e would work w ell because the halogens, chlorine and brom ine, a c t  as 
good leaving groups for nucleophilic addition. A lso, the halogens and the  
carboxyl group a c t  as good e lec tro n  w ithdrawers to  w eaken the double 
bond. An exam ple o f  th is m echanism  is shown in Fig. 36 using trans-3 -  
brom oacrylic acid . Addition o f the nucleophile by c leavage  o f the double 
bond and form ation o f the carbanion leads to  the subsequent loss o f  
brom ine and reform ation  o f the double bond. The carbanion can also  be 
stab ilized  by e lec tro n  w ithdraw al to  the carboxyl group.
This inform ation can also be applied in an explanation  o f  the 
d ifferen ces  in rate con stan ts b etw een  the ch loro- and brom oacrylic acids. 
Rappoport (33) has reported  on the e lem en t e f f e c t  (kgr/kQ]) for the 
reaction  o f  cis  and trans isom ers o f  one compound with various 
nucleophiles. One nucleophile studied  was (0 4 1 1 9 )2 NH which could behave 
nucleophilica lly  like an am ino acid  residue such as lysin e. Values o f  
k gr/k c i  for the trans compounds range from 0.74 to  1 .03 , which com pares 
quite w ell w ith the values ca lcu la ted  here o f  1.3 and 3 .1 . For the cis  
com pounds, reported values o f k gr/kQ i range from 1.4 to  4.2, while those  
ca lcu la ted  in this research  lie  in the range o f  0.95 to  1.6. Q ualita tively , 
th ese  values com pare quite w ell. In fa c t , the only notable d ifferen ce  is 
that Rappoport reports generally  higher e lem en t e f f e c t s  by the c is  isom ers, 
w hereas th is research  found the reverse to  be true. This e lem en t or 
substituent e f f e c t  can be attributed  largely  to the fa c t  that the brom ine-
FIGURE 36.
N ucleophilic addition and elim ination  o f  bromine from tra n s-3 -  
brom oacrylic acid .
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carbon bond is w eaker than the chlorine-carbon bond, thus, brom ine is the 
b etter  leaving group.
The m echanism  by which th is nucleophilic addition and its  subsequent 
elem en t e f f e c t  takes p lace is believed  to be the A ddition-E lim ination  
route. This m echanism  appears to  be more im portant than other possible  
sch em es for the fo llow ing reasons: the Snl  rou te, which would proceed by 
form ation o f  a v inylic carbonium ion and then nucleophilic a ttack , requires 
cleavage  o f the leav in g  group bond and stab iliza tion  o f the carbonium ion 
by e lec tro n  donating substituen ts. None o f  the inhibitors te sted  here  
contains the n ecessary  substituen ts, in fa c t  they  are a ll s tr ic t ly  electron  
withdrawing. Thus, the Snl  route is unlikely.
Another possible m echanism , the E lim ination-A ddition route (Fig. 37) 
could occur if  an ac id ic  hydrogen is loca ted  adjacent to  the carbon bound 
to  the leaving group. The presence o f  base could ab stract the proton and 
elim inate HX (w here X = halogen) to  form an a ce ty len e . Addition o f the 
nucleophile and a proton would yield  the substitu ted  product. H ow ever, this 
m echanism  seem s to  occur more o ften  in system s w here the only vinylic  
substituen t is the leav in g  group itse lf . In addition, this sch em e would not 
be possible for trans-acry lic  acids because the ac id ic  proton and the  
leaving group m ust be trans to  one another. B ecause the c is  isom er is 
favored in th is sch em e, one would see  high kc is /k -^rans values if  
E lim ination-A ddition w ere the m echanism . This is not the case , however, 
so th is m echanism  is also an unlikely one.
This lea v es  the A ddition-E lim ination route, described earlier and 
shown in Fig. 36, as the m ost likely , and there seem  to  be no indications to  
the contrary. Furtherm ore, this m echanism  provides a reasonable  
explanation for the c is/tra n s e f f e c t  observed for both the brom o- and
FIGURE 37.
The E lim ination-A ddition  route for nucleophilic substitu tion  as shown 
cis-3 -b rom oacry lic  acid.
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ch loroacrylics. This c is/tran s e f f e c t  stem s from the addition o f  the  
nucleophile perpendicular to  the plane o f the inhibitor m olecule at the 3 -  
carbon and form ation o f  tetrahedral geom etry  a t that carbon, as shown in 
Fig. 38 for c is -  and trans-3-ch loroacry lic  acids. R otation  o f either 60° or 
120° about the cen tra l carbon-carbon axis p laces the leaving group 
perpendicular to  the original plane o f the m olecu le, whereupon elim ination  
produces the substitu ted  product. With large or bulkly nucleophiles, as 
DA AO would be, the 30° rotation , and therefore, reten tion  o f  
configuration, is preferred  (33). This shorter rotation  is favored because o f  
the sev ere  eclip sing  in teractions upon rotation  by 120°. In addition, 
because the 60° rotation  causes the original configuration to  be produced  
a fter  nucleophilic substitu tion , one would ex p ect high k trans/k c js ratios  
because o f  s te r ic  hindrance produced b etw een  the enzym e nucleophile and 
the carboxyl group for the c is  isom er. This e f f e c t  would not be seen  for 
the trans isom er, which supports the rapid binding o f trans-3-brom o- and 
chloroacrylic acids to  DAAO.
The A ddition-E lim ination route is also the m ost favorable m echanism  
for the inhibition o f  DAAO by dibrom om aleic acid , although this is not as 
readily apparent. No m atter which side o f the plane o f  the dibrom om aleic  
acid  m olecule that the enzym e a ttack s, som e s te r ic  hindrance w ill be 
encountered  even  w ith a 60° rotation  about the cen tra l carbon-carbon  
bond. In this ca se , the favorab ility  o f the A ddition-E lim ination route is due 
to  its  re lian ce on good e lec tro n  withdrawing substituents. While the 
brom o- and ch loracrylic  acids each  have one halogen and one carboxyl 
substituent, dibrom om aleic acid  has tw o o f  each , lending to  an even  
stronger d e loca liza tion  o f the 11 -bond and thus, easier nucleophilic  
addition. This strong e lectron  withdrawing ab ility  o f  dibrom om aleic acid
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FIGURE 38.
N ucleophilic A ddition-H alogen E lim ination schem e for c is -  and trans-3 -  
ch loroacry lic  acids.
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seem s to outw eigh the s ter ic  hindrance produced upon covalen t  
m odification  o f the enzym e, for its  first-order rate constant is 
s ign ifican tly  higher than that o f  c is-3 -b rom oacry lic  acid. An additional 
advantage o f th is m echanism  with dibrom om aleic acid  resu lts from the  
m olecule's geom etry . N ucleophilic addition perpendicular to  the plane o f  
the m olecule from any o f the four possible d irections (above and below  at 
both carbons o f  the double bond) would yield  the sam e product. T herefore, 
a higher percentage o f those m olecu les reaching the a c tiv e  s ite  o f DAAO 
would be ex p ected  to  cova len tly  m odify the enzym e than in the case o f c is -  
3-brornoacrylic acid, for exam ple.
F inally , although the A ddition-Elim ination mechanism  o f nucleophilic  
substitu tion  provides good explanations for the c is/tran s e f f e c t  in the  
brom o- and ch loroacrylics and for the re la tiv e ly  good rea c tiv ity  o f 
dibrom om aleic acid , th is may not be the only factor  involved. Also 
im portant here are the location  o f  the nucleophile on the enzym e and the 
geom etry  o f  the a c tiv e  s ite . The possib ility  ex ists  that the re la tive  rates  
o f inhibition are a resu lt m erely  o f  the inhibitors' ab ilities  or inab ilities to  
f it  into the a c t iv e  s ite  based on the p lacem ent o f  their substituents.
C. Conclusions
The A ddition-E lim ination m echanism  o f nucleophilic substitu tion  
appears to  be a reasonably good schem e for explanation o f the c is/tran s  
e f fe c t s  observed in the inhibition o f  DAAO. Also, the observed e lem en t  
e f fe c t s  o f the ch loro- and brom oacrylic acids f it  in w ell with the  
requirem ents for good e lec tro n  withdrawing groups in this m echanism . 
These resu lts are based on the first-order rate constants ca lcu lated  from  
the inhibitor in jection  data. One m ust note that these rate constants are 
not precise  quantitative values, for the ex a c t order o f  the reaction s is
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unknown. H ow ever, they  do lend som e quantitative a sp ects  to the project 
because otherw ise, com parisons betw een  inhibitors would have to be made 
so le ly  on the basis o f  the double reciprocal p lots and in jection  curves. In 
addition, agreem ent with the literatu re values (33) supports their use.
Several im portant proposals for the continuation  o f  this research  
would include the com pletion  o f th is series o f halo-v iny lic  acids by 
exam ining the inhbition o f  DAAO by dibrom ofum aric acid , the trans isom er  
of dibrom om aleic acid . Another com parison that could provide valuable  
geom etric  and e lec tro n ic  inform ation about the a c tiv e  s it s  would be trans-  
2-brom oacrylic acid  vs. trans-3-brom oacrylic acid . This com parison would 
allow  one to te s t  the A ddition-Elim ination hypothesis in more d eta il. Vlost 
im portant would be the u ltim ate verifica tion  o f irreversib ility  perhaps 
through the syn thesis o f radiolabelled  inhibitor m olecules and proteolysis to  
determ ine which am ino acid  residues have been m odified.
Although n ot y e t com p lete , the use o f  th ese  five  a ffin ity  labelling  
agen ts in the inhibition o f  D -am ino acid  oxidase has provided inform ation  
that could la ter  lead  to  the developm ent o f  a p oten tia l su icide inhibitor. 
These developm ents, in turn, could lead  to  the determ ination  o f the 
physiological function  o f the enzym e.
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